Cayman

Showing 33601–33750 of 45550 results

  • Inhibition of thromboxane synthase (TXAS), especially in human platelets, has been a clinical objective for many years. 1-Alkyl (N-alkyl)-imidazole derivatives have been recognized as TXAS inhibitors since the early 1980s.{10335,10334,10336} Ozagrel is a 1-alkyl imidazole derivative that acts as a selective inhibitor of TXAS with an IC50 of 11 nM. The beneficial effects of TXAS inhibition by ozagrel include improved motor coordination after experimental stroke,{10146} and antihypertensive effects in spontaneously hypertensive rats.{10337}  

     

    Brand:
    Cayman
    SKU:70515 - 100 mg

    Available on backorder

  • Inhibition of thromboxane synthase (TXAS), especially in human platelets, has been a clinical objective for many years. 1-Alkyl (N-alkyl)-imidazole derivatives have been recognized as TXAS inhibitors since the early 1980s.{10335,10334,10336} Ozagrel is a 1-alkyl imidazole derivative that acts as a selective inhibitor of TXAS with an IC50 of 11 nM. The beneficial effects of TXAS inhibition by ozagrel include improved motor coordination after experimental stroke,{10146} and antihypertensive effects in spontaneously hypertensive rats.{10337}  

     

    Brand:
    Cayman
    SKU:70515 - 5 mg

    Available on backorder

  • Inhibition of thromboxane synthase (TXAS), especially in human platelets, has been a clinical objective for many years. 1-Alkyl (N-alkyl)-imidazole derivatives have been recognized as TXAS inhibitors since the early 1980s.{10335,10334,10336} Ozagrel is a 1-alkyl imidazole derivative that acts as a selective inhibitor of TXAS with an IC50 of 11 nM. The beneficial effects of TXAS inhibition by ozagrel include improved motor coordination after experimental stroke,{10146} and antihypertensive effects in spontaneously hypertensive rats.{10337}  

     

    Brand:
    Cayman
    SKU:70515 - 50 mg

    Available on backorder

  • Ozanimod is a selective, orally available modulator of the sphingosine-1-phosphate (S1P) receptors S1P1 and SIP5.{32048,32049} It induces internalization of S1P1, decreases circulating B and CCR7(+) T lymphocytes, and reduces inflammation and disease parameters in three autoimmune disease models.{32048} Ozanimod is in clinical trials for relapsing multiple sclerosis and ulcerative colitis.{32048,32047}  

     

    Brand:
    Cayman
    SKU:19922 -

    Available on backorder

  • Ozanimod is a selective, orally available modulator of the sphingosine-1-phosphate (S1P) receptors S1P1 and SIP5.{32048,32049} It induces internalization of S1P1, decreases circulating B and CCR7(+) T lymphocytes, and reduces inflammation and disease parameters in three autoimmune disease models.{32048} Ozanimod is in clinical trials for relapsing multiple sclerosis and ulcerative colitis.{32048,32047}  

     

    Brand:
    Cayman
    SKU:19922 -

    Available on backorder

  • Ozanimod is a selective, orally available modulator of the sphingosine-1-phosphate (S1P) receptors S1P1 and SIP5.{32048,32049} It induces internalization of S1P1, decreases circulating B and CCR7(+) T lymphocytes, and reduces inflammation and disease parameters in three autoimmune disease models.{32048} Ozanimod is in clinical trials for relapsing multiple sclerosis and ulcerative colitis.{32048,32047}  

     

    Brand:
    Cayman
    SKU:19922 -

    Available on backorder

  • Ozanimod is a selective, orally available modulator of the sphingosine-1-phosphate (S1P) receptors S1P1 and SIP5.{32048,32049} It induces internalization of S1P1, decreases circulating B and CCR7(+) T lymphocytes, and reduces inflammation and disease parameters in three autoimmune disease models.{32048} Ozanimod is in clinical trials for relapsing multiple sclerosis and ulcerative colitis.{32048,32047}  

     

    Brand:
    Cayman
    SKU:19922 -

    Available on backorder

  • p-APMSF is an irreversible inhibitor of serine proteases with Ki values of 1.02, 1.18, 1.5, and 1.54 µM for bovine trypsin, human thrombin, bovine plasmin, and bovine Factor Xa, respectively.{25670} It is selective for these proteases over bovine chymotrypsin and acetylcholinesterase.  

     

    Brand:
    Cayman
    SKU:-
  • p-APMSF is an irreversible inhibitor of serine proteases with Ki values of 1.02, 1.18, 1.5, and 1.54 µM for bovine trypsin, human thrombin, bovine plasmin, and bovine Factor Xa, respectively.{25670} It is selective for these proteases over bovine chymotrypsin and acetylcholinesterase.  

     

    Brand:
    Cayman
    SKU:-
  • p-APMSF is an irreversible inhibitor of serine proteases with Ki values of 1.02, 1.18, 1.5, and 1.54 µM for bovine trypsin, human thrombin, bovine plasmin, and bovine Factor Xa, respectively.{25670} It is selective for these proteases over bovine chymotrypsin and acetylcholinesterase.  

     

    Brand:
    Cayman
    SKU:-
  • p-APMSF is an irreversible inhibitor of serine proteases with Ki values of 1.02, 1.18, 1.5, and 1.54 µM for bovine trypsin, human thrombin, bovine plasmin, and bovine Factor Xa, respectively.{25670} It is selective for these proteases over bovine chymotrypsin and acetylcholinesterase.  

     

    Brand:
    Cayman
    SKU:-
  • p-chloro Phenylalanine is an inhibitor of tryptophan hydroxylase (Ki = 300 µM).{47198} It acts as a competitive inhibitor in vitro and an irreversible inhibitor in vivo. It depletes serotonin to undetectable levels in rats after six days when administered at a dose of 300 mg/kg. p-chloro Phenylalanine has commonly been used to deplete brain serotonin levels in animal studies of the serotonergic system and its involvement in depressive-like behavior, reward learning, Parkinson’s disease, and pain.{47199,47200,47201,47202}  

     

    Brand:
    Cayman
    SKU:26168 - 10 g

    Available on backorder

  • p-chloro Phenylalanine is an inhibitor of tryptophan hydroxylase (Ki = 300 µM).{47198} It acts as a competitive inhibitor in vitro and an irreversible inhibitor in vivo. It depletes serotonin to undetectable levels in rats after six days when administered at a dose of 300 mg/kg. p-chloro Phenylalanine has commonly been used to deplete brain serotonin levels in animal studies of the serotonergic system and its involvement in depressive-like behavior, reward learning, Parkinson’s disease, and pain.{47199,47200,47201,47202}  

     

    Brand:
    Cayman
    SKU:26168 - 100 g

    Available on backorder

  • p-chloro Phenylalanine is an inhibitor of tryptophan hydroxylase (Ki = 300 µM).{47198} It acts as a competitive inhibitor in vitro and an irreversible inhibitor in vivo. It depletes serotonin to undetectable levels in rats after six days when administered at a dose of 300 mg/kg. p-chloro Phenylalanine has commonly been used to deplete brain serotonin levels in animal studies of the serotonergic system and its involvement in depressive-like behavior, reward learning, Parkinson’s disease, and pain.{47199,47200,47201,47202}  

     

    Brand:
    Cayman
    SKU:26168 - 25 g

    Available on backorder

  • p-chloro Phenylalanine is an inhibitor of tryptophan hydroxylase (Ki = 300 µM).{47198} It acts as a competitive inhibitor in vitro and an irreversible inhibitor in vivo. It depletes serotonin to undetectable levels in rats after six days when administered at a dose of 300 mg/kg. p-chloro Phenylalanine has commonly been used to deplete brain serotonin levels in animal studies of the serotonergic system and its involvement in depressive-like behavior, reward learning, Parkinson’s disease, and pain.{47199,47200,47201,47202}  

     

    Brand:
    Cayman
    SKU:26168 - 50 g

    Available on backorder

  • p-Coumaric acid is a hydroxy derivative of cinnamic acid that can be found in a variety of edible plants that is reported to have antioxidant, anti-inflammatory, and antimicrobial activity.{25720} It has been shown to activate L. plantarum microbial functions in the intestine, including a strong antioxidant response and detoxification mechanisms.{32957}  

     

    Brand:
    Cayman
    SKU:20929 -

    Out of stock

  • p-Coumaric acid is a hydroxy derivative of cinnamic acid that can be found in a variety of edible plants that is reported to have antioxidant, anti-inflammatory, and antimicrobial activity.{25720} It has been shown to activate L. plantarum microbial functions in the intestine, including a strong antioxidant response and detoxification mechanisms.{32957}  

     

    Brand:
    Cayman
    SKU:20929 -

    Out of stock

  • p-Coumaric acid is a hydroxy derivative of cinnamic acid that can be found in a variety of edible plants that is reported to have antioxidant, anti-inflammatory, and antimicrobial activity.{25720} It has been shown to activate L. plantarum microbial functions in the intestine, including a strong antioxidant response and detoxification mechanisms.{32957}  

     

    Brand:
    Cayman
    SKU:20929 -

    Out of stock

  • p-Coumaric acid is a hydroxy derivative of cinnamic acid that can be found in a variety of edible plants that is reported to have antioxidant, anti-inflammatory, and antimicrobial activity.{25720} It has been shown to activate L. plantarum microbial functions in the intestine, including a strong antioxidant response and detoxification mechanisms.{32957}  

     

    Brand:
    Cayman
    SKU:20929 -

    Out of stock

  • p-Cresol sulfate is a sulfate conjugate of the uremic toxin p-cresol, which is formed by bacterial fermentation of proteins in the large intestine.{45960,45961} p-Cresol sulfate increases migration and proliferation of isolated rat aortic vascular smooth muscle cells (VSMCs) when used at a concentration of 500 µM.{45962} It also increases the area of aortic atherosclerotic plaques in nephrectomized ApoE-/- mice fed a high-fat diet when administered at a dose of 100 mg/kg per day via the drinking water. Serum levels of total and free p-cresol sulfate are increased in patients with advanced stage chronic kidney disease and positively associated with vascular calcification.{45963}  

     

    Brand:
    Cayman
    SKU:29504 - 1 g

    Available on backorder

  • p-Cresol sulfate is a sulfate conjugate of the uremic toxin p-cresol, which is formed by bacterial fermentation of proteins in the large intestine.{45960,45961} p-Cresol sulfate increases migration and proliferation of isolated rat aortic vascular smooth muscle cells (VSMCs) when used at a concentration of 500 µM.{45962} It also increases the area of aortic atherosclerotic plaques in nephrectomized ApoE-/- mice fed a high-fat diet when administered at a dose of 100 mg/kg per day via the drinking water. Serum levels of total and free p-cresol sulfate are increased in patients with advanced stage chronic kidney disease and positively associated with vascular calcification.{45963}  

     

    Brand:
    Cayman
    SKU:29504 - 100 mg

    Available on backorder

  • p-Cresol sulfate is a sulfate conjugate of the uremic toxin p-cresol, which is formed by bacterial fermentation of proteins in the large intestine.{45960,45961} p-Cresol sulfate increases migration and proliferation of isolated rat aortic vascular smooth muscle cells (VSMCs) when used at a concentration of 500 µM.{45962} It also increases the area of aortic atherosclerotic plaques in nephrectomized ApoE-/- mice fed a high-fat diet when administered at a dose of 100 mg/kg per day via the drinking water. Serum levels of total and free p-cresol sulfate are increased in patients with advanced stage chronic kidney disease and positively associated with vascular calcification.{45963}  

     

    Brand:
    Cayman
    SKU:29504 - 250 mg

    Available on backorder

  • p-Cresol sulfate is a sulfate conjugate of the uremic toxin p-cresol, which is formed by bacterial fermentation of proteins in the large intestine.{45960,45961} p-Cresol sulfate increases migration and proliferation of isolated rat aortic vascular smooth muscle cells (VSMCs) when used at a concentration of 500 µM.{45962} It also increases the area of aortic atherosclerotic plaques in nephrectomized ApoE-/- mice fed a high-fat diet when administered at a dose of 100 mg/kg per day via the drinking water. Serum levels of total and free p-cresol sulfate are increased in patients with advanced stage chronic kidney disease and positively associated with vascular calcification.{45963}  

     

    Brand:
    Cayman
    SKU:29504 - 500 mg

    Available on backorder

  • p-Cymene is a monoterpene that is found in a variety of plants, including C. sativa, and has diverse biological activities, including antimicrobial, anticancer, antioxidant, anti-inflammatory, antinociceptive, and anxiolytic properties.{42351,38639} p-Cymene inhibits the growth of S. typhimurium, E. coli, L. monocytogenes, S. epidermidis, and S. aureus with MIC values ranging from 0.266 to 0.608% v/v.{42352} It decreases the invasive activity of HT-1080 human fibrosarcoma cells in vitro by 87% when used at a concentration of 600 µM.{42353} In mouse hippocampus, p-Cymene (50 mg/kg, i.p.) reduces lipid peroxidation and nitrite content by 65.5 and 71.2%, respectively, and increases superoxide dismutase (SOD) and catalase activities by 22.7 and 119.3%, respectively, compared to vehicle control animals.{42354} Formulations containing p-cymene have been used as flavoring agents.  

     

    Brand:
    Cayman
    SKU:23159 - 100 mg

    Available on backorder

  • p-Hydroxyhippuric acid is a dihydroxy phenolic acid inhibitor of organic anion transporter 1 (OAT1; IC50 = 25 µM in opossum kidney cells).{48924} It increases the production of free radicals in opossum kidney cells expressing human OAT1. p-Hydroxyhippuric acid reduces the secretion of TNF-α, but not IL-1β or IL-6, in isolated human peripheral blood mononuclear cells (PBMCs) stimulated with LPS by 30.4% when used at a concentration of 1 µM.{48925}  

     

    Brand:
    Cayman
    SKU:30115 - 1 g

    Available on backorder

  • p-Hydroxyhippuric acid is a dihydroxy phenolic acid inhibitor of organic anion transporter 1 (OAT1; IC50 = 25 µM in opossum kidney cells).{48924} It increases the production of free radicals in opossum kidney cells expressing human OAT1. p-Hydroxyhippuric acid reduces the secretion of TNF-α, but not IL-1β or IL-6, in isolated human peripheral blood mononuclear cells (PBMCs) stimulated with LPS by 30.4% when used at a concentration of 1 µM.{48925}  

     

    Brand:
    Cayman
    SKU:30115 - 100 mg

    Available on backorder

  • p-Hydroxyhippuric acid is a dihydroxy phenolic acid inhibitor of organic anion transporter 1 (OAT1; IC50 = 25 µM in opossum kidney cells).{48924} It increases the production of free radicals in opossum kidney cells expressing human OAT1. p-Hydroxyhippuric acid reduces the secretion of TNF-α, but not IL-1β or IL-6, in isolated human peripheral blood mononuclear cells (PBMCs) stimulated with LPS by 30.4% when used at a concentration of 1 µM.{48925}  

     

    Brand:
    Cayman
    SKU:30115 - 250 mg

    Available on backorder

  • p-Hydroxyhippuric acid is a dihydroxy phenolic acid inhibitor of organic anion transporter 1 (OAT1; IC50 = 25 µM in opossum kidney cells).{48924} It increases the production of free radicals in opossum kidney cells expressing human OAT1. p-Hydroxyhippuric acid reduces the secretion of TNF-α, but not IL-1β or IL-6, in isolated human peripheral blood mononuclear cells (PBMCs) stimulated with LPS by 30.4% when used at a concentration of 1 µM.{48925}  

     

    Brand:
    Cayman
    SKU:30115 - 500 mg

    Available on backorder

  • Clonidine (Item No. 15949) is an antihypertensive α2-adrenergic receptor agonist. p-iodo-Clonidine is a partial agonist of the α2-adrenergic receptor, minimally inhibiting adenylate cyclase through this Gi protein-coupled receptor although it binds avidly (Ki = 1.0 nM).{28190} It potentiates platelet aggregation by ADP (EC50 = 1.5 µM) and inhibits epinephrine-induced aggregation (IC50 = 5.1 µM).{28190}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Clonidine (Item No. 15949) is an antihypertensive α2-adrenergic receptor agonist. p-iodo-Clonidine is a partial agonist of the α2-adrenergic receptor, minimally inhibiting adenylate cyclase through this Gi protein-coupled receptor although it binds avidly (Ki = 1.0 nM).{28190} It potentiates platelet aggregation by ADP (EC50 = 1.5 µM) and inhibits epinephrine-induced aggregation (IC50 = 5.1 µM).{28190}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Clonidine (Item No. 15949) is an antihypertensive α2-adrenergic receptor agonist. p-iodo-Clonidine is a partial agonist of the α2-adrenergic receptor, minimally inhibiting adenylate cyclase through this Gi protein-coupled receptor although it binds avidly (Ki = 1.0 nM).{28190} It potentiates platelet aggregation by ADP (EC50 = 1.5 µM) and inhibits epinephrine-induced aggregation (IC50 = 5.1 µM).{28190}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Pifithrin-α (PFT-α; Item No. 13326) is an inactivator of p53 that blocks p53-dependent transcriptional activation and apoptosis.{17259} Cyclic PFT-α (Item No. 14748) is a stable analog of PFT-α.{23585} p-nitro-Cyclic PFT-α is a cell-permeable form of cyclic PFT-α.{23578} It is one order of magnitude more active that PFT-α in protecting cortical neurons exposed to etoposide (ED50 = 30 nM).{23578} p-nitro-Cyclic PFT-α acts in a p53-dependent manner but does not block phosphorylation of p53 on Ser15 in response to etoposide treatment, although it prevents p53 posttranscriptional activity.{23578} Although it is more stable in solution than the parent compound, this derivative is not active in vivo.{23578}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Pifithrin-α (PFT-α; Item No. 13326) is an inactivator of p53 that blocks p53-dependent transcriptional activation and apoptosis.{17259} Cyclic PFT-α (Item No. 14748) is a stable analog of PFT-α.{23585} p-nitro-Cyclic PFT-α is a cell-permeable form of cyclic PFT-α.{23578} It is one order of magnitude more active that PFT-α in protecting cortical neurons exposed to etoposide (ED50 = 30 nM).{23578} p-nitro-Cyclic PFT-α acts in a p53-dependent manner but does not block phosphorylation of p53 on Ser15 in response to etoposide treatment, although it prevents p53 posttranscriptional activity.{23578} Although it is more stable in solution than the parent compound, this derivative is not active in vivo.{23578}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Pifithrin-α (PFT-α; Item No. 13326) is an inactivator of p53 that blocks p53-dependent transcriptional activation and apoptosis.{17259} Cyclic PFT-α (Item No. 14748) is a stable analog of PFT-α.{23585} p-nitro-Cyclic PFT-α is a cell-permeable form of cyclic PFT-α.{23578} It is one order of magnitude more active that PFT-α in protecting cortical neurons exposed to etoposide (ED50 = 30 nM).{23578} p-nitro-Cyclic PFT-α acts in a p53-dependent manner but does not block phosphorylation of p53 on Ser15 in response to etoposide treatment, although it prevents p53 posttranscriptional activity.{23578} Although it is more stable in solution than the parent compound, this derivative is not active in vivo.{23578}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Pifithrin-α (PFT-α; Item No. 13326) is an inactivator of p53 that blocks p53-dependent transcriptional activation and apoptosis.{17259} Cyclic PFT-α (Item No. 14748) is a stable analog of PFT-α.{23585} p-nitro-Cyclic PFT-α is a cell-permeable form of cyclic PFT-α.{23578} It is one order of magnitude more active that PFT-α in protecting cortical neurons exposed to etoposide (ED50 = 30 nM).{23578} p-nitro-Cyclic PFT-α acts in a p53-dependent manner but does not block phosphorylation of p53 on Ser15 in response to etoposide treatment, although it prevents p53 posttranscriptional activity.{23578} Although it is more stable in solution than the parent compound, this derivative is not active in vivo.{23578}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Pifithrin-α (Item No. 13326) is an inactivator of p53 that blocks p53-dependent transcriptional activation and apoptosis.{17259} p-nitro-Pifithrin-α is a cell-permeable analog of pifithrin-α.{23578} It blocks p53-mediated expression of p21/WAF1 and apoptosis in cortical neurons ten-fold more potently than pifithrin-α.{23578} p-nitro-Pifithrin-α, at 10 µM, suppresses p53-mediated TGF-β1 expression in human proximal tubular cells and attenuates steatosis and liver injury in mice fed a high-fat diet.{26427,26428} It is slowly converted into a more potent cyclized form, p-nitro cyclic pifithrin-α, when incubated in biological media (t½ = 8 h).{23578}  

     

    Brand:
    Cayman
    SKU:-
  • Pifithrin-α (Item No. 13326) is an inactivator of p53 that blocks p53-dependent transcriptional activation and apoptosis.{17259} p-nitro-Pifithrin-α is a cell-permeable analog of pifithrin-α.{23578} It blocks p53-mediated expression of p21/WAF1 and apoptosis in cortical neurons ten-fold more potently than pifithrin-α.{23578} p-nitro-Pifithrin-α, at 10 µM, suppresses p53-mediated TGF-β1 expression in human proximal tubular cells and attenuates steatosis and liver injury in mice fed a high-fat diet.{26427,26428} It is slowly converted into a more potent cyclized form, p-nitro cyclic pifithrin-α, when incubated in biological media (t½ = 8 h).{23578}  

     

    Brand:
    Cayman
    SKU:-
  • Pifithrin-α (Item No. 13326) is an inactivator of p53 that blocks p53-dependent transcriptional activation and apoptosis.{17259} p-nitro-Pifithrin-α is a cell-permeable analog of pifithrin-α.{23578} It blocks p53-mediated expression of p21/WAF1 and apoptosis in cortical neurons ten-fold more potently than pifithrin-α.{23578} p-nitro-Pifithrin-α, at 10 µM, suppresses p53-mediated TGF-β1 expression in human proximal tubular cells and attenuates steatosis and liver injury in mice fed a high-fat diet.{26427,26428} It is slowly converted into a more potent cyclized form, p-nitro cyclic pifithrin-α, when incubated in biological media (t½ = 8 h).{23578}  

     

    Brand:
    Cayman
    SKU:-
  • Pifithrin-α (Item No. 13326) is an inactivator of p53 that blocks p53-dependent transcriptional activation and apoptosis.{17259} p-nitro-Pifithrin-α is a cell-permeable analog of pifithrin-α.{23578} It blocks p53-mediated expression of p21/WAF1 and apoptosis in cortical neurons ten-fold more potently than pifithrin-α.{23578} p-nitro-Pifithrin-α, at 10 µM, suppresses p53-mediated TGF-β1 expression in human proximal tubular cells and attenuates steatosis and liver injury in mice fed a high-fat diet.{26427,26428} It is slowly converted into a more potent cyclized form, p-nitro cyclic pifithrin-α, when incubated in biological media (t½ = 8 h).{23578}  

     

    Brand:
    Cayman
    SKU:-
  • p-Nitrobenzyl mesylate (PNBM) is a reagent that is used to alkylate thiophosphates, forming thiophosphate ester epitopes that can be recognized by specific antibodies.{34226} Substrates phosphorylated with adenosine 5′-(γ-thio)-triphosphate (ATPγS; Item No. 14957) or N6-benzyl-ATPγS can be alkylated by PNBM.{34227,34228} The tagged substrates can be isolated by immunoprecipitation or immunoaffinity purification, or they can be detected by immunoblotting.  

     

    Brand:
    Cayman
    SKU:21456 -

    Out of stock

  • p-Nitrobenzyl mesylate (PNBM) is a reagent that is used to alkylate thiophosphates, forming thiophosphate ester epitopes that can be recognized by specific antibodies.{34226} Substrates phosphorylated with adenosine 5′-(γ-thio)-triphosphate (ATPγS; Item No. 14957) or N6-benzyl-ATPγS can be alkylated by PNBM.{34227,34228} The tagged substrates can be isolated by immunoprecipitation or immunoaffinity purification, or they can be detected by immunoblotting.  

     

    Brand:
    Cayman
    SKU:21456 -

    Out of stock

  • p-Nitrobenzyl mesylate (PNBM) is a reagent that is used to alkylate thiophosphates, forming thiophosphate ester epitopes that can be recognized by specific antibodies.{34226} Substrates phosphorylated with adenosine 5′-(γ-thio)-triphosphate (ATPγS; Item No. 14957) or N6-benzyl-ATPγS can be alkylated by PNBM.{34227,34228} The tagged substrates can be isolated by immunoprecipitation or immunoaffinity purification, or they can be detected by immunoblotting.  

     

    Brand:
    Cayman
    SKU:21456 -

    Out of stock

  • p-Nitrophenylphosphorylcholine is a chromogenic substrate that is used to measure phospholipase C (PLC) activity.{33067,33068,33069,33070} Hydrolysis of p-nitrophenylphosphorylcholine by PLC results in the liberation of p-nitrophenol, which can be measured at 405 nm at pH 7.2-7.5.  

     

    Brand:
    Cayman
    SKU:21042 -

    Out of stock

  • p-Nitrophenylphosphorylcholine is a chromogenic substrate that is used to measure phospholipase C (PLC) activity.{33067,33068,33069,33070} Hydrolysis of p-nitrophenylphosphorylcholine by PLC results in the liberation of p-nitrophenol, which can be measured at 405 nm at pH 7.2-7.5.  

     

    Brand:
    Cayman
    SKU:21042 -

    Out of stock

  • p-Nitrophenylphosphorylcholine is a chromogenic substrate that is used to measure phospholipase C (PLC) activity.{33067,33068,33069,33070} Hydrolysis of p-nitrophenylphosphorylcholine by PLC results in the liberation of p-nitrophenol, which can be measured at 405 nm at pH 7.2-7.5.  

     

    Brand:
    Cayman
    SKU:21042 -

    Out of stock

  • p-Nitrophenylphosphorylcholine is a chromogenic substrate that is used to measure phospholipase C (PLC) activity.{33067,33068,33069,33070} Hydrolysis of p-nitrophenylphosphorylcholine by PLC results in the liberation of p-nitrophenol, which can be measured at 405 nm at pH 7.2-7.5.  

     

    Brand:
    Cayman
    SKU:21042 -

    Out of stock

  • p,p’-DDD is a metabolite of the organochlorine pesticide DDT.{36698} It is an agonist at estrogen receptor α (ERα) and ERβ, increasing transactivation with 20% relative effective concentrations (REC20) of 3.2 and 2.4 µM, respectively, in CHO-K1 cells expressing the human receptors.{42200} It inhibits DHT-induced androgen receptor transcription with a 20% relative inhibitory concentration (RIC20) of 0.71 µM. p,p’-DDD increases apoptosis in isolated human peripheral blood mononuclear cells (PBMCs) when used at concentrations of 100 and 150 µg/ml.{36699} Blood levels of p,p’-DDD and the level of PBMC apoptosis are increased in children exposed to DDT compared with unexposed children. It is not considered lethal to hamsters (LD50 = ~5,000 mg/kg) but is to rats (LD50 = 3,750 mg/kg).{36700}  

     

    Brand:
    Cayman
    SKU:24234 - 100 mg

    Available on backorder

  • p,p’-DDE is a metabolite and degradation product of the organochlorine pesticide DDT.{39801} It accumulates in smallmouth buffalo, channel catfish, and largemouth bass as well as sediment in the Huntsville Spring Branch-Indian Creek tributary system surrounding a DDT manufacturing plant where it is considered a persistent organic pollutant (POP). p,p’-DDE inhibits estrogen binding to rainbow trout estrogen receptors (rtERs) with an IC50 value of 8 µM.{12991} It induces concentration-dependent secretion of estradiol by granulosa and theca cell co-cultures isolated from porcine ovarian follicles.{39802} p,p’-DDE (50-100 µM) also decreases ATP levels, the proportion of sperm with high mitochondrial membrane potential, and motility of human sperm in vitro.{42280}  

     

    Brand:
    Cayman
    SKU:24241 - 100 mg

    Available on backorder

  • p,p’-DDE is a metabolite and degradation product of the organochlorine pesticide DDT.{39801} It accumulates in smallmouth buffalo, channel catfish, and largemouth bass as well as sediment in the Huntsville Spring Branch-Indian Creek tributary system surrounding a DDT manufacturing plant where it is considered a persistent organic pollutant (POP). p,p’-DDE inhibits estrogen binding to rainbow trout estrogen receptors (rtERs) with an IC50 value of 8 µM.{12991} It induces concentration-dependent secretion of estradiol by granulosa and theca cell co-cultures isolated from porcine ovarian follicles.{39802} p,p’-DDE (50-100 µM) also decreases ATP levels, the proportion of sperm with high mitochondrial membrane potential, and motility of human sperm in vitro.{42280}  

     

    Brand:
    Cayman
    SKU:24241 - 50 mg

    Available on backorder

  • p,p’-DDT is an organochlorine pesticide that induces 94.2% mortality of malaria mosquito (A. quadrimaculatus) fourth-instar larvae and 100% mortality of A. aegypti larvae when used at concentrations of 0.01 and 0.05 ppm, respectively.{37594,37593} It increases secretion of estradiol by granulosa and theca cell co-cultures isolated from porcine ovarian follicles when used at concentrations of greater than or equal to 4 ng/ml and increases apoptosis in isolated human peripheral blood mononuclear cells (PBMCs) when used at concentrations ranging from 80 to 150 µg/ml.{36699,39802} p,p’-DDT (5 nmol/kg, i.p.) increases tumor growth in a DLD1 colorectal adenocarcinoma nude mouse xenograft model.{43286} It induces 100% mortality of C. auratus (goldfish) at 0.25 ppm and is lethal to rats but not hamsters (LD50s = 120 and ~5,000 mg/kg, respectively).{36700,37594} p,p’-DDT is a persistent organic pollutant (POP) and is elevated in the sera of pregnant women in malaria-endemic regions of South Africa.{37597} Formulations containing p,p’-DDT have been used to control insect populations, including mosquitos, in agriculture and to prevent the spread of malaria and typhus.  

     

    Brand:
    Cayman
    SKU:24243 - 1 mg

    Available on backorder

  • p,p’-DDT is an organochlorine pesticide that induces 94.2% mortality of malaria mosquito (A. quadrimaculatus) fourth-instar larvae and 100% mortality of A. aegypti larvae when used at concentrations of 0.01 and 0.05 ppm, respectively.{37594,37593} It increases secretion of estradiol by granulosa and theca cell co-cultures isolated from porcine ovarian follicles when used at concentrations of greater than or equal to 4 ng/ml and increases apoptosis in isolated human peripheral blood mononuclear cells (PBMCs) when used at concentrations ranging from 80 to 150 µg/ml.{36699,39802} p,p’-DDT (5 nmol/kg, i.p.) increases tumor growth in a DLD1 colorectal adenocarcinoma nude mouse xenograft model.{43286} It induces 100% mortality of C. auratus (goldfish) at 0.25 ppm and is lethal to rats but not hamsters (LD50s = 120 and ~5,000 mg/kg, respectively).{36700,37594} p,p’-DDT is a persistent organic pollutant (POP) and is elevated in the sera of pregnant women in malaria-endemic regions of South Africa.{37597} Formulations containing p,p’-DDT have been used to control insect populations, including mosquitos, in agriculture and to prevent the spread of malaria and typhus.  

     

    Brand:
    Cayman
    SKU:24243 - 10 mg

    Available on backorder

  • p,p’-DDT is an organochlorine pesticide that induces 94.2% mortality of malaria mosquito (A. quadrimaculatus) fourth-instar larvae and 100% mortality of A. aegypti larvae when used at concentrations of 0.01 and 0.05 ppm, respectively.{37594,37593} It increases secretion of estradiol by granulosa and theca cell co-cultures isolated from porcine ovarian follicles when used at concentrations of greater than or equal to 4 ng/ml and increases apoptosis in isolated human peripheral blood mononuclear cells (PBMCs) when used at concentrations ranging from 80 to 150 µg/ml.{36699,39802} p,p’-DDT (5 nmol/kg, i.p.) increases tumor growth in a DLD1 colorectal adenocarcinoma nude mouse xenograft model.{43286} It induces 100% mortality of C. auratus (goldfish) at 0.25 ppm and is lethal to rats but not hamsters (LD50s = 120 and ~5,000 mg/kg, respectively).{36700,37594} p,p’-DDT is a persistent organic pollutant (POP) and is elevated in the sera of pregnant women in malaria-endemic regions of South Africa.{37597} Formulations containing p,p’-DDT have been used to control insect populations, including mosquitos, in agriculture and to prevent the spread of malaria and typhus.  

     

    Brand:
    Cayman
    SKU:24243 - 25 mg

    Available on backorder

  • p,p’-DDT is an organochlorine pesticide that induces 94.2% mortality of malaria mosquito (A. quadrimaculatus) fourth-instar larvae and 100% mortality of A. aegypti larvae when used at concentrations of 0.01 and 0.05 ppm, respectively.{37594,37593} It increases secretion of estradiol by granulosa and theca cell co-cultures isolated from porcine ovarian follicles when used at concentrations of greater than or equal to 4 ng/ml and increases apoptosis in isolated human peripheral blood mononuclear cells (PBMCs) when used at concentrations ranging from 80 to 150 µg/ml.{36699,39802} p,p’-DDT (5 nmol/kg, i.p.) increases tumor growth in a DLD1 colorectal adenocarcinoma nude mouse xenograft model.{43286} It induces 100% mortality of C. auratus (goldfish) at 0.25 ppm and is lethal to rats but not hamsters (LD50s = 120 and ~5,000 mg/kg, respectively).{36700,37594} p,p’-DDT is a persistent organic pollutant (POP) and is elevated in the sera of pregnant women in malaria-endemic regions of South Africa.{37597} Formulations containing p,p’-DDT have been used to control insect populations, including mosquitos, in agriculture and to prevent the spread of malaria and typhus.  

     

    Brand:
    Cayman
    SKU:24243 - 5 mg

    Available on backorder

  • p,p’-Dicofol is an organochlorine pesticide that is active against mites.{41953} It is an agonist of the estrogen receptor (EC50 = 1.6 µM for human recombinant receptors).  

     

    Brand:
    Cayman
    SKU:24244 - 100 mg

    Available on backorder

  • p,p’-Dicofol is an organochlorine pesticide that is active against mites.{41953} It is an agonist of the estrogen receptor (EC50 = 1.6 µM for human recombinant receptors).  

     

    Brand:
    Cayman
    SKU:24244 - 50 mg

    Available on backorder

  • Ubiquitin-specific proteases (USP/UBP) remove ubiquitin from proteins, sparing them from degradation by the proteasome. USP7 is a cysteine protease associated with prostate cancer that selectively deubiquitylates HDM2, the ubiquitin E3 ligase for the tumor suppressor p53. P005091 is a trisubstituted thiophene that inhibits USP7 and the closely related USP47 (EC50s = 4.2 and 4.3 μM, respectively) with little activity against other classes of proteases, including caspases, cathepsins, calpain, metalloproteases, and serine proteases (EC50s = > 100 μM).{24461,24462} P005091 has been shown to accelerate the degradation of the USP7 substrate HDM2 in several multiple myeloma cell lines (EC50 = 11 μM) and to inhibit the growth of HCT116 human colorectal cancer cells (EC50 = 11 μM) synergistically with doxorubicin, etoposide, or mechlorethamine.{24461} In vivo, 10 mg/kg P005091 prolongs survival and reduces tumor growth in mice bearing human multiple myeloma and B cell leukemia xenografts.{24461}  

     

    Brand:
    Cayman
    SKU:-
  • Ubiquitin-specific proteases (USP/UBP) remove ubiquitin from proteins, sparing them from degradation by the proteasome. USP7 is a cysteine protease associated with prostate cancer that selectively deubiquitylates HDM2, the ubiquitin E3 ligase for the tumor suppressor p53. P005091 is a trisubstituted thiophene that inhibits USP7 and the closely related USP47 (EC50s = 4.2 and 4.3 μM, respectively) with little activity against other classes of proteases, including caspases, cathepsins, calpain, metalloproteases, and serine proteases (EC50s = > 100 μM).{24461,24462} P005091 has been shown to accelerate the degradation of the USP7 substrate HDM2 in several multiple myeloma cell lines (EC50 = 11 μM) and to inhibit the growth of HCT116 human colorectal cancer cells (EC50 = 11 μM) synergistically with doxorubicin, etoposide, or mechlorethamine.{24461} In vivo, 10 mg/kg P005091 prolongs survival and reduces tumor growth in mice bearing human multiple myeloma and B cell leukemia xenografts.{24461}  

     

    Brand:
    Cayman
    SKU:-
  • Ubiquitin-specific proteases (USP/UBP) remove ubiquitin from proteins, sparing them from degradation by the proteasome. USP7 is a cysteine protease associated with prostate cancer that selectively deubiquitylates HDM2, the ubiquitin E3 ligase for the tumor suppressor p53. P005091 is a trisubstituted thiophene that inhibits USP7 and the closely related USP47 (EC50s = 4.2 and 4.3 μM, respectively) with little activity against other classes of proteases, including caspases, cathepsins, calpain, metalloproteases, and serine proteases (EC50s = > 100 μM).{24461,24462} P005091 has been shown to accelerate the degradation of the USP7 substrate HDM2 in several multiple myeloma cell lines (EC50 = 11 μM) and to inhibit the growth of HCT116 human colorectal cancer cells (EC50 = 11 μM) synergistically with doxorubicin, etoposide, or mechlorethamine.{24461} In vivo, 10 mg/kg P005091 prolongs survival and reduces tumor growth in mice bearing human multiple myeloma and B cell leukemia xenografts.{24461}  

     

    Brand:
    Cayman
    SKU:-
  • Ubiquitin-specific proteases (USP/UBP) remove ubiquitin from proteins, sparing them from degradation by the proteasome. USP7 is a cysteine protease associated with prostate cancer that selectively deubiquitylates HDM2, the ubiquitin E3 ligase for the tumor suppressor p53. P005091 is a trisubstituted thiophene that inhibits USP7 and the closely related USP47 (EC50s = 4.2 and 4.3 μM, respectively) with little activity against other classes of proteases, including caspases, cathepsins, calpain, metalloproteases, and serine proteases (EC50s = > 100 μM).{24461,24462} P005091 has been shown to accelerate the degradation of the USP7 substrate HDM2 in several multiple myeloma cell lines (EC50 = 11 μM) and to inhibit the growth of HCT116 human colorectal cancer cells (EC50 = 11 μM) synergistically with doxorubicin, etoposide, or mechlorethamine.{24461} In vivo, 10 mg/kg P005091 prolongs survival and reduces tumor growth in mice bearing human multiple myeloma and B cell leukemia xenografts.{24461}  

     

    Brand:
    Cayman
    SKU:-
  • P005672 is a tetracycline antibiotic that has activity against S. aureus RN450, S. pneumoniae 157E-strep, P. acnes ATCC 6919 and ATCC 11827, E. coli ATCC 25922 and MG 1655, and B. thetaiotaomicron, in vitro, when used at concentrations less than or equal to 8 μg/ml.{36678} It is non-cytotoxic to COS-1 and CHO cells (IC50 = >75 μg/ml for both) and is less phototoxic to 3T3 fibroblasts than doxycycline (Item No. 14422; IC50s = >25 and In vivo, P005672 increases survival in a mouse model of lethal S. aureus RN450 infection with a protective dose (PD50) value of 0.13 mg/kg. It also reduces paw edema in a rat model of carrageenan-induced inflammation.  

     

    Brand:
    Cayman
    SKU:24685 - 1 mg

    Available on backorder

  • P005672 is a tetracycline antibiotic that has activity against S. aureus RN450, S. pneumoniae 157E-strep, P. acnes ATCC 6919 and ATCC 11827, E. coli ATCC 25922 and MG 1655, and B. thetaiotaomicron, in vitro, when used at concentrations less than or equal to 8 μg/ml.{36678} It is non-cytotoxic to COS-1 and CHO cells (IC50 = >75 μg/ml for both) and is less phototoxic to 3T3 fibroblasts than doxycycline (Item No. 14422; IC50s = >25 and In vivo, P005672 increases survival in a mouse model of lethal S. aureus RN450 infection with a protective dose (PD50) value of 0.13 mg/kg. It also reduces paw edema in a rat model of carrageenan-induced inflammation.  

     

    Brand:
    Cayman
    SKU:24685 - 10 mg

    Available on backorder

  • P005672 is a tetracycline antibiotic that has activity against S. aureus RN450, S. pneumoniae 157E-strep, P. acnes ATCC 6919 and ATCC 11827, E. coli ATCC 25922 and MG 1655, and B. thetaiotaomicron, in vitro, when used at concentrations less than or equal to 8 μg/ml.{36678} It is non-cytotoxic to COS-1 and CHO cells (IC50 = >75 μg/ml for both) and is less phototoxic to 3T3 fibroblasts than doxycycline (Item No. 14422; IC50s = >25 and In vivo, P005672 increases survival in a mouse model of lethal S. aureus RN450 infection with a protective dose (PD50) value of 0.13 mg/kg. It also reduces paw edema in a rat model of carrageenan-induced inflammation.  

     

    Brand:
    Cayman
    SKU:24685 - 25 mg

    Available on backorder

  • P005672 is a tetracycline antibiotic that has activity against S. aureus RN450, S. pneumoniae 157E-strep, P. acnes ATCC 6919 and ATCC 11827, E. coli ATCC 25922 and MG 1655, and B. thetaiotaomicron, in vitro, when used at concentrations less than or equal to 8 μg/ml.{36678} It is non-cytotoxic to COS-1 and CHO cells (IC50 = >75 μg/ml for both) and is less phototoxic to 3T3 fibroblasts than doxycycline (Item No. 14422; IC50s = >25 and In vivo, P005672 increases survival in a mouse model of lethal S. aureus RN450 infection with a protective dose (PD50) value of 0.13 mg/kg. It also reduces paw edema in a rat model of carrageenan-induced inflammation.  

     

    Brand:
    Cayman
    SKU:24685 - 5 mg

    Available on backorder

  • P1075 is a potent activator of sulfonylurea receptor 2-associated ATP-sensitive potassium channels (SUR2-Kir6) with an EC50 value of 45 nM for SUR2B-Kir6 channel activation.{38539} It is highly selective for SUR2 over SUR1 isoforms (IC50s = 9-46 nM and 1.02 mM, respectively, in a radioligand binding assay). P1075 increases outflow facility, a marker of reduced intraocular pressure, in human eye anterior segments ex vivo.{38540} It also reduces infarct size in isolated rabbit hearts via activation of mitochondrial ATP-sensitive potassium channels (KATP; EC50s = 60-90 nM).{38541}  

     

    Brand:
    Cayman
    SKU:21849 -

    Out of stock

  • P1075 is a potent activator of sulfonylurea receptor 2-associated ATP-sensitive potassium channels (SUR2-Kir6) with an EC50 value of 45 nM for SUR2B-Kir6 channel activation.{38539} It is highly selective for SUR2 over SUR1 isoforms (IC50s = 9-46 nM and 1.02 mM, respectively, in a radioligand binding assay). P1075 increases outflow facility, a marker of reduced intraocular pressure, in human eye anterior segments ex vivo.{38540} It also reduces infarct size in isolated rabbit hearts via activation of mitochondrial ATP-sensitive potassium channels (KATP; EC50s = 60-90 nM).{38541}  

     

    Brand:
    Cayman
    SKU:21849 -

    Out of stock

  • Lipoprotein-associated phospholipase A2, also known as platelet activating factor acetylhydrolase (PAF-AH) or phospholipase A2 group 7, hydrolyzes glycerophospholipids to produce lyso-PAF/lyso-phosphatidylcholine and short and/or oxidized fatty acids, many of which have pro-inflammatory or pro-oxidative activities. PAF-AH1b2 and 1b3 form a complex with 1b1 to regulate brain development, spermatogenesis, and cancer pathogenesis. P11 is an inhibitor of PAF-AH1b2- and 1b3-mediated hydrolysis of PAF to lyso-PAF (IC50s = 37 and 880 nM, respectively) without significant effect on other brain serine hydrolases.{28330} At 10 µM, it has been shown to impair Neuro2a and PC3 tumor cell survival.{28330}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Lipoprotein-associated phospholipase A2, also known as platelet activating factor acetylhydrolase (PAF-AH) or phospholipase A2 group 7, hydrolyzes glycerophospholipids to produce lyso-PAF/lyso-phosphatidylcholine and short and/or oxidized fatty acids, many of which have pro-inflammatory or pro-oxidative activities. PAF-AH1b2 and 1b3 form a complex with 1b1 to regulate brain development, spermatogenesis, and cancer pathogenesis. P11 is an inhibitor of PAF-AH1b2- and 1b3-mediated hydrolysis of PAF to lyso-PAF (IC50s = 37 and 880 nM, respectively) without significant effect on other brain serine hydrolases.{28330} At 10 µM, it has been shown to impair Neuro2a and PC3 tumor cell survival.{28330}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Lipoprotein-associated phospholipase A2, also known as platelet activating factor acetylhydrolase (PAF-AH) or phospholipase A2 group 7, hydrolyzes glycerophospholipids to produce lyso-PAF/lyso-phosphatidylcholine and short and/or oxidized fatty acids, many of which have pro-inflammatory or pro-oxidative activities. PAF-AH1b2 and 1b3 form a complex with 1b1 to regulate brain development, spermatogenesis, and cancer pathogenesis. P11 is an inhibitor of PAF-AH1b2- and 1b3-mediated hydrolysis of PAF to lyso-PAF (IC50s = 37 and 880 nM, respectively) without significant effect on other brain serine hydrolases.{28330} At 10 µM, it has been shown to impair Neuro2a and PC3 tumor cell survival.{28330}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Lipoprotein-associated phospholipase A2, also known as platelet activating factor acetylhydrolase (PAF-AH) or phospholipase A2 group 7, hydrolyzes glycerophospholipids to produce lyso-PAF/lyso-phosphatidylcholine and short and/or oxidized fatty acids, many of which have pro-inflammatory or pro-oxidative activities. PAF-AH1b2 and 1b3 form a complex with 1b1 to regulate brain development, spermatogenesis, and cancer pathogenesis. P11 is an inhibitor of PAF-AH1b2- and 1b3-mediated hydrolysis of PAF to lyso-PAF (IC50s = 37 and 880 nM, respectively) without significant effect on other brain serine hydrolases.{28330} At 10 µM, it has been shown to impair Neuro2a and PC3 tumor cell survival.{28330}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • P22077 is a dual inhibitor of the deubiquitylating enzymes ubiquitin-specific protease 7 (USP7) and USP47 (EC50s = 8.01 and 8.74 µM, respectively, in a fluorescence-based enzyme assay).{27951} It is selective for USP7 and USP47 over other USPs and proteases with EC50 values greater than 50 µM. P22077 (25 µM) induces the accumulation of polyubiquitinated proteins in HEK293 cells. In neuroblastoma cells in vitro, P22077 blocks deubiquitylation of HDM2, a protein that normally deubiquitinates the tumor suppressor p53 leading to its degradation.{39388} When used at concentrations of 10 and 20 µM, it amplifies the cytotoxicity and p53-mediated apoptosis of doxorubicin (Item No. 15007) and etoposide (Item No. 12092) in neuroblastoma cells. P22077 inhibits tumor growth in neuroblastoma mouse xenograft models when administered at a dose of 20 mg/kg per day.  

     

    Brand:
    Cayman
    SKU:23704 - 10 mg

    Available on backorder

  • P22077 is a dual inhibitor of the deubiquitylating enzymes ubiquitin-specific protease 7 (USP7) and USP47 (EC50s = 8.01 and 8.74 µM, respectively, in a fluorescence-based enzyme assay).{27951} It is selective for USP7 and USP47 over other USPs and proteases with EC50 values greater than 50 µM. P22077 (25 µM) induces the accumulation of polyubiquitinated proteins in HEK293 cells. In neuroblastoma cells in vitro, P22077 blocks deubiquitylation of HDM2, a protein that normally deubiquitinates the tumor suppressor p53 leading to its degradation.{39388} When used at concentrations of 10 and 20 µM, it amplifies the cytotoxicity and p53-mediated apoptosis of doxorubicin (Item No. 15007) and etoposide (Item No. 12092) in neuroblastoma cells. P22077 inhibits tumor growth in neuroblastoma mouse xenograft models when administered at a dose of 20 mg/kg per day.  

     

    Brand:
    Cayman
    SKU:23704 - 25 mg

    Available on backorder

  • P22077 is a dual inhibitor of the deubiquitylating enzymes ubiquitin-specific protease 7 (USP7) and USP47 (EC50s = 8.01 and 8.74 µM, respectively, in a fluorescence-based enzyme assay).{27951} It is selective for USP7 and USP47 over other USPs and proteases with EC50 values greater than 50 µM. P22077 (25 µM) induces the accumulation of polyubiquitinated proteins in HEK293 cells. In neuroblastoma cells in vitro, P22077 blocks deubiquitylation of HDM2, a protein that normally deubiquitinates the tumor suppressor p53 leading to its degradation.{39388} When used at concentrations of 10 and 20 µM, it amplifies the cytotoxicity and p53-mediated apoptosis of doxorubicin (Item No. 15007) and etoposide (Item No. 12092) in neuroblastoma cells. P22077 inhibits tumor growth in neuroblastoma mouse xenograft models when administered at a dose of 20 mg/kg per day.  

     

    Brand:
    Cayman
    SKU:23704 - 5 mg

    Available on backorder

  • P22077 is a dual inhibitor of the deubiquitylating enzymes ubiquitin-specific protease 7 (USP7) and USP47 (EC50s = 8.01 and 8.74 µM, respectively, in a fluorescence-based enzyme assay).{27951} It is selective for USP7 and USP47 over other USPs and proteases with EC50 values greater than 50 µM. P22077 (25 µM) induces the accumulation of polyubiquitinated proteins in HEK293 cells. In neuroblastoma cells in vitro, P22077 blocks deubiquitylation of HDM2, a protein that normally deubiquitinates the tumor suppressor p53 leading to its degradation.{39388} When used at concentrations of 10 and 20 µM, it amplifies the cytotoxicity and p53-mediated apoptosis of doxorubicin (Item No. 15007) and etoposide (Item No. 12092) in neuroblastoma cells. P22077 inhibits tumor growth in neuroblastoma mouse xenograft models when administered at a dose of 20 mg/kg per day.  

     

    Brand:
    Cayman
    SKU:23704 - 50 mg

    Available on backorder

  • The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are responsible for a majority of nutrient-stimulated insulin secretion. After being released into the circulation, GIP and GLP-1 are inactivated by the circulating enzyme dipeptidyl peptidase IV (DPP IV). DPP IV inhibitors have emerged as a new class of experimental antidiabetic agents. P32/98 is a competitive transition-state substrate analog inhibitor of DPP IV (Ki = 126 nM).{24373} At 20 mg/kg/day, it has been used to improve glucose tolerance, insulin sensitivity, and β-cell glucose responsiveness in diabetic rat models.{27894}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are responsible for a majority of nutrient-stimulated insulin secretion. After being released into the circulation, GIP and GLP-1 are inactivated by the circulating enzyme dipeptidyl peptidase IV (DPP IV). DPP IV inhibitors have emerged as a new class of experimental antidiabetic agents. P32/98 is a competitive transition-state substrate analog inhibitor of DPP IV (Ki = 126 nM).{24373} At 20 mg/kg/day, it has been used to improve glucose tolerance, insulin sensitivity, and β-cell glucose responsiveness in diabetic rat models.{27894}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are responsible for a majority of nutrient-stimulated insulin secretion. After being released into the circulation, GIP and GLP-1 are inactivated by the circulating enzyme dipeptidyl peptidase IV (DPP IV). DPP IV inhibitors have emerged as a new class of experimental antidiabetic agents. P32/98 is a competitive transition-state substrate analog inhibitor of DPP IV (Ki = 126 nM).{24373} At 20 mg/kg/day, it has been used to improve glucose tolerance, insulin sensitivity, and β-cell glucose responsiveness in diabetic rat models.{27894}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • The three mitogen-activated protein kinases (MAPKs) are evolutionarily conserved protein kinases that control a vast array of cellular processes. p38 MAPK is one of these kinases and it is activated by both inflammatory cytokines and by stress.{14317,14326} The p38 MAPK is thought to be particularly important in diseases like asthma and autoimmunity but it also plays important roles in the stress response of the nervous system.{14318,14325} Like the other MAPKs, p38 is activated by a dual specificity kinase that phosphorylates Thr180 and Tyr182.{14316}  

     

    Brand:
    Cayman
    SKU:10009177 - 1 ea

    Available on backorder

  • Antigen: phosphopeptide corresponding to amino acid residues surrounding phospho-Thr180 and phospho-Tyr182 of rat p38 MAPK • Host: rabbit • Cross Reactivity: (+) human p38 MAPK • Application(s): WB • p38 MAPK is activated by both inflammatory cytokines and by stress. It is thought to be particularly important in diseases like asthma and autoimmunity but it also plays important roles in the stress response of the nervous system. Like the other MAPKs, p38 is activated by a dual specificity kinase that phosphorylates Thr180 and Tyr182.  

     

    Brand:
    Cayman
    SKU:10009177- 1 ea

    Available on backorder

  • Antigen: phosphopeptide corresponding to amino acid residues surrounding phospho-Thr180 and phospho-Tyr182 of rat p38 MAPK • Host: rabbit • Cross Reactivity: (+) human p38 MAPK • Application(s): WB • p38 MAPK is activated by both inflammatory cytokines and by stress. It is thought to be particularly important in diseases like asthma and autoimmunity but it also plays important roles in the stress response of the nervous system. Like the other MAPKs, p38 is activated by a dual specificity kinase that phosphorylates Thr180 and Tyr182.  

     

    Brand:
    Cayman
    SKU:10009177- 1 ea
  • p38 MAPK inhibitor is a potent inhibitor of p38 MAP kinase (IC50 = 35 nM).{28765} It inhibits senescence induced by the oncogene RAS.{28766}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • p38 MAPK inhibitor is a potent inhibitor of p38 MAP kinase (IC50 = 35 nM).{28765} It inhibits senescence induced by the oncogene RAS.{28766}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • p38 MAPK inhibitor is a potent inhibitor of p38 MAP kinase (IC50 = 35 nM).{28765} It inhibits senescence induced by the oncogene RAS.{28766}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • p38 MAPK inhibitor IV is an ATP-competitive inhibitor of p38 MAP kinases with IC50 values of 0.13, 0.55, 5.47, and 8.63 μM for p38α, p38β, p38 , and p38δ, respectively, in vitro.{37130} It also inhibits LPS-induced TNF-α and IL-1β cytokine production (IC50s = 22 and 44 nM, respectively) in human peripheral blood mononuclear cells.  

     

    Brand:
    Cayman
    SKU:22219 -

    Out of stock

  • p38 MAPK inhibitor IV is an ATP-competitive inhibitor of p38 MAP kinases with IC50 values of 0.13, 0.55, 5.47, and 8.63 μM for p38α, p38β, p38 , and p38δ, respectively, in vitro.{37130} It also inhibits LPS-induced TNF-α and IL-1β cytokine production (IC50s = 22 and 44 nM, respectively) in human peripheral blood mononuclear cells.  

     

    Brand:
    Cayman
    SKU:22219 -

    Out of stock

  • p38 MAPK inhibitor IV is an ATP-competitive inhibitor of p38 MAP kinases with IC50 values of 0.13, 0.55, 5.47, and 8.63 μM for p38α, p38β, p38 , and p38δ, respectively, in vitro.{37130} It also inhibits LPS-induced TNF-α and IL-1β cytokine production (IC50s = 22 and 44 nM, respectively) in human peripheral blood mononuclear cells.  

     

    Brand:
    Cayman
    SKU:22219 -

    Out of stock

  • p38 MAP kinase inhibitor VIII is an inhibitor of p38α (IC50 = 39 nM) and p38β MAP kinases with 82 and 93% inhibition, respectively, in a kinase assay when used at a concentration of 1 µM.{38865} It is selective for p38α and 38β, lacking activity at p38γ, p38δ, ERK1/2, and JNK1 at a concentration of 1 µM. p38 MAP kinase inhibitor VIII inhibits IL-1β, TNF-α, IL-6, IL-8, and IL-10, but not IFN-γ release from human peripheral blood mononuclear cells (PBMCs; IC50s = 30, 5, 17, 4, 10, and >1,000 nM, respectively). It also decreases ear swelling in mouse models of allergic and chronic irritative contact dermatitis when administered topically at a dose of 0.5 mg/ear.  

     

    Brand:
    Cayman
    SKU:21229 -

    Out of stock

  • p38 MAP kinase inhibitor VIII is an inhibitor of p38α (IC50 = 39 nM) and p38β MAP kinases with 82 and 93% inhibition, respectively, in a kinase assay when used at a concentration of 1 µM.{38865} It is selective for p38α and 38β, lacking activity at p38γ, p38δ, ERK1/2, and JNK1 at a concentration of 1 µM. p38 MAP kinase inhibitor VIII inhibits IL-1β, TNF-α, IL-6, IL-8, and IL-10, but not IFN-γ release from human peripheral blood mononuclear cells (PBMCs; IC50s = 30, 5, 17, 4, 10, and >1,000 nM, respectively). It also decreases ear swelling in mouse models of allergic and chronic irritative contact dermatitis when administered topically at a dose of 0.5 mg/ear.  

     

    Brand:
    Cayman
    SKU:21229 -

    Out of stock

  • p38 MAP kinase inhibitor VIII is an inhibitor of p38α (IC50 = 39 nM) and p38β MAP kinases with 82 and 93% inhibition, respectively, in a kinase assay when used at a concentration of 1 µM.{38865} It is selective for p38α and 38β, lacking activity at p38γ, p38δ, ERK1/2, and JNK1 at a concentration of 1 µM. p38 MAP kinase inhibitor VIII inhibits IL-1β, TNF-α, IL-6, IL-8, and IL-10, but not IFN-γ release from human peripheral blood mononuclear cells (PBMCs; IC50s = 30, 5, 17, 4, 10, and >1,000 nM, respectively). It also decreases ear swelling in mouse models of allergic and chronic irritative contact dermatitis when administered topically at a dose of 0.5 mg/ear.  

     

    Brand:
    Cayman
    SKU:21229 -

    Out of stock

  • Antigen: human full length p38 MAPK • Host: mouse, clone 9F12 • Cross Reactivity: (+) human, mouse, and rat p38 MAPK • Application(s): FC, ICC, and WB • p38 MAPK is a member of the serine-threonine MAPK family that triggers many cellular processes including cell cycle, development, and apoptosis.  

     

    Brand:
    Cayman
    SKU:10011301- 1 ea
  • p38 mitogen-activated protein kinase (MAPK) is a member of the serine-threonine MAPK family that triggers many cellular processes including cell cycle, development, and apoptosis.{15420,15421} These kinases are activated by environmental stress signals such as osmotic shock, infection, and cytokines causing phosphorylation of p38 MAPK. This results in a phosphorylation cascade, activating transcription factors, and inducing gene expression.{15420,15424} p38 MAPK is widely expressed in heart, brain, skeletal muscle, platelets, and immune cells. Due to this distribution, p38 MAPK plays a role in cardiovascular disease, arthritis, and cancer.{15421,15422,1523,15424} It is mainly present in the cytosol, but can also be found in the nucleus after activation.{15421} Based on the amino acid sequence, the expected molecular weight of this protein is 41 kDa.  

     

    Brand:
    Cayman
    SKU:10011301 - 1 ea

    Available on backorder

  • Antigen: human full length p38 MAPK • Host: mouse, clone 9F12 • Cross Reactivity: (+) human, mouse, and rat p38 MAPK • Application(s): FC, ICC, and WB • p38 MAPK is a member of the serine-threonine MAPK family that triggers many cellular processes including cell cycle, development, and apoptosis.  

     

    Brand:
    Cayman
    SKU:10011301- 1 ea

    Available on backorder

  • Immunogen: Peptide corresponding to human p38α MAPK (phospho-Thr180/Tyr182) • Host: Rabbit • Species Reactivity: (+) Human • Cross Reactivity: (+) p38α MAPK (phospho-Thr180/Tyr182); (-) Unmodified p38α MAPK, p38α MAPK (phospho-Thr180), p38α MAPK (phospho-Tyr182) • Applications: IHC, WB • MW: ~38 kDa  

     

    Brand:
    Cayman
    SKU:32197- 100 µl

    Available on backorder

  • Immunogen: Peptide corresponding to human p38α MAPK (phospho-Thr180/Tyr182) • Host: Rabbit • Species Reactivity: (+) Human • Cross Reactivity: (+) p38α MAPK (phospho-Thr180/Tyr182); (-) Unmodified p38α MAPK, p38α MAPK (phospho-Thr180), p38α MAPK (phospho-Tyr182) • Applications: IHC, WB • MW: ~38 kDa  

     

    Brand:
    Cayman
    SKU:32197- 100 µl
  • p38 MAPK is a serine/threonine protein kinase and member of the MAPK family with roles in the regulation of immune responses and embryonic development, as well as cell differentiation, metabolism, and survival.{60066,60067} It exists as 4 isoforms, p38α, -β, -γ, and -δ, encoded by MAPK14, MAPK11, MAPK12, and MAPK13, respectively, in humans. p38α MAPK is ubiquitously expressed, with the highest levels of expression in the heart, skeletal muscle, and brain.{60066,60068} It is activated via dual phosphorylation of threonine 180 (Thr180) and tyrosine 182 (Tyr182) by the MAP2K kinases MKK3 and MKK6 in response to LPS or the production of inflammatory cytokines and induces signaling through protein kinases, transcription factors, and transcriptional regulators, among others.{60066,60067} Levels of activated p38α MAPK (p38α phospho-Thr180/Tyr182) are increased and positively correlated with apoptosis in DU145 and PC3 prostate cancer cells in response to cisplatin (Item No. 13119).{60070} p38α Phospho-Thr180/Tyr182 levels are also increased in adult rat ventricular monocytes during stimulated ischemia.{60071} Cayman’s p38α MAPK (Phospho-Thr180/Tyr182) Rabbit Monoclonal Antibody can be used for immunohistochemistry (IHC) and Western blot (WB) applications. The antibody recognizes p38α MAPK (phospho-Thr180/Tyr182) at approximately 38 kDa from human samples.  

     

    Brand:
    Cayman
    SKU:32197 - 100 µl

    Available on backorder

  • Immunogen: Peptide corresponding to p38α MAPK (300-360) • Host: Rabbit • Species Reactivity: (+) Human • Applications: IHC, WB • MW: ~38 kDa  

     

    Brand:
    Cayman
    SKU:32199- 100 µl

    Available on backorder

  • Immunogen: Peptide corresponding to p38α MAPK (300-360) • Host: Rabbit • Species Reactivity: (+) Human • Applications: IHC, WB • MW: ~38 kDa  

     

    Brand:
    Cayman
    SKU:32199- 100 µl
  • p38 MAPK is a serine/threonine protein kinase and member of the MAPK family with roles in the regulation of immune responses and embryonic development, as well as cell differentiation, metabolism, and survival.{60066,60067} It exists as 4 isoforms, p38α, -β, -γ, and -δ, encoded by MAPK14, MAPK11, MAPK12, and MAPK13, respectively, in humans. p38α MAPK is ubiquitously expressed, with the highest levels of expression in heart, skeletal muscle, and brain.{60066,60068} It is activated via dual phosphorylation of threonine 180 and tyrosine 182 by the MAP2K kinases MKK3 and MKK6 in response to LPS or the production of inflammatory cytokines.{60066,60067} Downstream signaling targets of p38α MAPK include protein kinases, transcription factors, and transcriptional regulators, among others.{60067} Knockdown of Mapk14 is embryonic lethal, while macrophage-specific deletion of Mapk14 inhibits inflammatory cytokine production and is protective against cecal ligation and puncture-induced sepsis in mice.{60067,60068} Mapk14 knockdown also increases lysosomal degradation of β-secretase 1 (BACE1) and decreases amyloid-β (Aβ) production in the APP/PS1 double transgenic mouse model of Alzheimer’s disease.{60069} Cayman’s p38α MAPK Monoclonal Antibody (Clone RM245) can be used for immunohistochemistry (IHC) and Western blot (WB) applications. The antibody recognizes p38α MAPK at approximately 38 kDa from human samples.  

     

    Brand:
    Cayman
    SKU:32199 - 100 µl

    Available on backorder

  • Antigen: amino acids around phospho-Ser392 • Host: rabbit • Application(s): WB • Nearly 50% of human tumors have mutated or non-functional p53. p53 amino acid residues can be modified by phosphorylation and acetylation. In vivo phosphorylation of p53 residues alters signal transduction events that warrant further investigation.  

     

    Brand:
    Cayman
    SKU:10004807- 1 ea

    Available on backorder

  • Antigen: amino acids around phospho-Ser392 • Host: rabbit • Application(s): WB • Nearly 50% of human tumors have mutated or non-functional p53. p53 amino acid residues can be modified by phosphorylation and acetylation. In vivo phosphorylation of p53 residues alters signal transduction events that warrant further investigation.  

     

    Brand:
    Cayman
    SKU:10004807- 1 ea
  • This antibody was purified by sequential peptide-affinity chromatography to select only for IgG specific for p53 (Ser392). Cellular p53, often called the ‘guardian of the genome’, is a transcription factor that is activated in response to cellular stress (DNA damage, hypoxia, heat shock, etc.) and acts to prevent further proliferation of the stressed cell by induction of cell cycle arrest or apoptotic mediators.{8237} Nearly 50% of human tumors have mutated or non-functional p53. p53 amino acid residues can be modified by phosphorylation and acetylation. In vivo phosphorylation of p53 residues alters signal transduction that warrant further investigation.{11275,11834}  

     

    Brand:
    Cayman
    SKU:10004807 - 1 ea

    Available on backorder

  • Epitope: Binds to N-terminal amino acids 16-25 of wild-type and mutant p53 • Host: Mouse • Clone: BP53-12 • Isotype: IgG2a • Species Reactivity: (+) Human and mouse; other species not tested • Applications: FC, IHC (paraffin-embedded tissue), IP, and WB • Cellular p53, often called the ‘guardian of the genome,’ is a transcription factor that is activated in response to cellular stress (DNA damage, hypoxia, heat shock, etc.) and acts to prevent further proliferation of the stressed cell by induction of cell cycle arrest or apoptotic mediators.  

     

    Brand:
    Cayman
    SKU:10004806- 1 ea

    Available on backorder

  • Epitope: Binds to N-terminal amino acids 16-25 of wild-type and mutant p53 • Host: Mouse • Clone: BP53-12 • Isotype: IgG2a • Species Reactivity: (+) Human and mouse; other species not tested • Applications: FC, IHC (paraffin-embedded tissue), IP, and WB • Cellular p53, often called the ‘guardian of the genome,’ is a transcription factor that is activated in response to cellular stress (DNA damage, hypoxia, heat shock, etc.) and acts to prevent further proliferation of the stressed cell by induction of cell cycle arrest or apoptotic mediators.  

     

    Brand:
    Cayman
    SKU:10004806- 1 ea
  • Epitope: Binds to N-terminal amino acids 16-25 of wild-type and mutant p53 Cellular p53, often called the ‘guardian of the genome,’ is a transcription factor that is activated in response to cellular stress (DNA damage, hypoxia, heat shock, etc.) and acts to prevent further proliferation of the stressed cell by induction of cell cycle arrest or apoptotic mediators.{8237} Nearly 50% of human tumors have mutated or non-functional p53. This antibody is suitable for a variety of techniques to distinguish between p53 positive and p53 negative tumors.{11929} This antibody binds the N-terminal (amino acids 16-25) of wild-type and mutant p53. This antibody does not work with frozen tissue sections. Cayman’s p53 Monoclonal Antibody (Clone BP53-12) can be used for flow cytometry, immunohistochemistry, immunoprecipitation, and Western blot applications. The antibody recognizes p53 at 53 kDa from human and mouse samples.  

     

    Brand:
    Cayman
    SKU:10004806 - 1 ea

    Available on backorder

  • The tumor suppressor protein p53 plays a crucial role in coordinating cellular responses to genotoxic stress and holds many important clinical implications in the treatment of cancer. Cayman’s p53 Transcription Factor Assay is a non-radioactive, sensitive method for detecting specific transcription factor DNA binding activity in nuclear extracts. A specific double-stranded DNA (dsDNA) sequence containing the p53 response element is immobilized onto the wells of a 96-well plate. p53 contained in a nuclear extract, binds specifically to the p53 response element and is detected by addition of a specific primary antibody directed against p53. A secondary antibody conjugated to HRP is added to provide a sensitive colorimetric readout at 450 nm.  

     

    Brand:
    Cayman
    SKU:600020 - 96 wells

    Available on backorder

  • p62, also known as sequestosome-1 (SQSTM1), is a 62 kDa protein that acts as a signaling hub and autophagy substrate and adaptor.{39547,39548} It is a multi-domain protein that includes a Phox1 and Bem1p (PB1) domain, a zinc finger, a tumor necrosis factor receptor-associated factor 6 (TRAF6) binding domain, a ubiquitin-associated (UBA) domain, LC3- and Keap1-interacting regions, as well as two nuclear localization and one nuclear export sequence. p62/SQSTM1 is constitutively expressed and is primarily localized in the cytoplasm, however, it is also expressed in the nucleus, autophagosomes, lysosomes, and inclusion bodies containing polyubiquitinated protein aggregates. It is overexpressed in a variety of human cancer cells as well as in the chronic liver diseases alcoholic and non-alcoholic steatohepatitis (NASH). p62/SQSTM1 binds to ERK1, RIP1, TRAF6, Raptor, PKC, LC3, and Keap1 to activate mammalian target of rapamycin complex 1 (mTORC1), NF-κB, and nuclear factor erythroid 2-related factor 2 (NRF2) signaling in response to oxidative and endoplasmic reticulum (ER) stress. It functions as a cargo receptor in selective autophagy to shuttle aggregated and damaged proteins and organelles to autophagosomes for clearance. Mutations in the UBA domain of the SQSTM1 gene are associated with Paget’s diseases. Cayman’s p62/SQSTM1 Polyclonal Antibody can be used for WB and ELISA applications. The antibody recognizes p62/SQSTM1 at ~60 kDa from human samples.  

     

    Brand:
    Cayman
    SKU:24693 - 500 µl

    Available on backorder

  • Immunogen: A synthetic peptide from the C-terminal region of human p62 • Host: Rabbit • Species Reactivity: (+) Human • Applications: ELISA and WB  

     

    Brand:
    Cayman
    SKU:24693- 500 µl

    Available on backorder

  • Immunogen: A synthetic peptide from the C-terminal region of human p62 • Host: Rabbit • Species Reactivity: (+) Human • Applications: ELISA and WB  

     

    Brand:
    Cayman
    SKU:24693- 500 µl
  • P7C3 is an orally bioavailable and brain penetrant aminopropyl carbazole that exhibits proneurogenic and neuroprotective activity by preventing apoptosis of newly postmitotic neurons in the subgranular zone of the hippocampal dentate gyrus.{27449} At doses of 5 mg/kg and above, it has been shown to promote the survival of neurons in various rodent models of neurodegeneration or nerve injury.{27447,27448} While the precise mechanism of action through which these effects are exerted remains uncertain, P7C3 recently has been shown to bind nicotinamide phosphoribosyltransferase, the rate-limiting enzyme involved in the conversion of nicotinamide into NAD.{27340}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • P7C3 is an orally bioavailable and brain penetrant aminopropyl carbazole that exhibits proneurogenic and neuroprotective activity by preventing apoptosis of newly postmitotic neurons in the subgranular zone of the hippocampal dentate gyrus.{27449} At doses of 5 mg/kg and above, it has been shown to promote the survival of neurons in various rodent models of neurodegeneration or nerve injury.{27447,27448} While the precise mechanism of action through which these effects are exerted remains uncertain, P7C3 recently has been shown to bind nicotinamide phosphoribosyltransferase, the rate-limiting enzyme involved in the conversion of nicotinamide into NAD.{27340}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • P7C3 is an orally bioavailable and brain penetrant aminopropyl carbazole that exhibits proneurogenic and neuroprotective activity by preventing apoptosis of newly postmitotic neurons in the subgranular zone of the hippocampal dentate gyrus.{27449} At doses of 5 mg/kg and above, it has been shown to promote the survival of neurons in various rodent models of neurodegeneration or nerve injury.{27447,27448} While the precise mechanism of action through which these effects are exerted remains uncertain, P7C3 recently has been shown to bind nicotinamide phosphoribosyltransferase, the rate-limiting enzyme involved in the conversion of nicotinamide into NAD.{27340}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • P7C3 is an orally bioavailable and brain penetrant aminopropyl carbazole that exhibits proneurogenic and neuroprotective activity by preventing apoptosis of newly postmitotic neurons in the subgranular zone of the hippocampal dentate gyrus.{27449} At doses of 5 mg/kg and above, it has been shown to promote the survival of neurons in various rodent models of neurodegeneration or nerve injury.{27447,27448} While the precise mechanism of action through which these effects are exerted remains uncertain, P7C3 recently has been shown to bind nicotinamide phosphoribosyltransferase, the rate-limiting enzyme involved in the conversion of nicotinamide into NAD.{27340}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • P7C3-A20 is a derivative of P7C3 (Item No. 16682) that has proneurogenic and neuroprotective activity.{41657} It increases proliferation in the subgranular zone (SGZ) of the adult mouse dentate gyrus in a dose-dependent manner when administered at doses ranging from 0.1 to 10 µM. It also protects U2OS cells from calcium-induced mitochondrial dissolution. In a rat model of traumatic brain injury, P7C3-A20 (10 mg/kg, i.p., twice daily for one week) decreases contusion volume, increases proliferation in the SGZ, and decreases the latency to reach the platform in the Morris water maze to sham surgery control levels.{41658} It also prevents or reverses dopaminergic cell death and motor deficits in a 6-OHDA rat model of Parkinson’s disease.{41659}  

     

    Brand:
    Cayman
    SKU:24201 - 1 mg

    Available on backorder

  • P7C3-A20 is a derivative of P7C3 (Item No. 16682) that has proneurogenic and neuroprotective activity.{41657} It increases proliferation in the subgranular zone (SGZ) of the adult mouse dentate gyrus in a dose-dependent manner when administered at doses ranging from 0.1 to 10 µM. It also protects U2OS cells from calcium-induced mitochondrial dissolution. In a rat model of traumatic brain injury, P7C3-A20 (10 mg/kg, i.p., twice daily for one week) decreases contusion volume, increases proliferation in the SGZ, and decreases the latency to reach the platform in the Morris water maze to sham surgery control levels.{41658} It also prevents or reverses dopaminergic cell death and motor deficits in a 6-OHDA rat model of Parkinson’s disease.{41659}  

     

    Brand:
    Cayman
    SKU:24201 - 10 mg

    Available on backorder

  • P7C3-A20 is a derivative of P7C3 (Item No. 16682) that has proneurogenic and neuroprotective activity.{41657} It increases proliferation in the subgranular zone (SGZ) of the adult mouse dentate gyrus in a dose-dependent manner when administered at doses ranging from 0.1 to 10 µM. It also protects U2OS cells from calcium-induced mitochondrial dissolution. In a rat model of traumatic brain injury, P7C3-A20 (10 mg/kg, i.p., twice daily for one week) decreases contusion volume, increases proliferation in the SGZ, and decreases the latency to reach the platform in the Morris water maze to sham surgery control levels.{41658} It also prevents or reverses dopaminergic cell death and motor deficits in a 6-OHDA rat model of Parkinson’s disease.{41659}  

     

    Brand:
    Cayman
    SKU:24201 - 25 mg

    Available on backorder

  • P7C3-A20 is a derivative of P7C3 (Item No. 16682) that has proneurogenic and neuroprotective activity.{41657} It increases proliferation in the subgranular zone (SGZ) of the adult mouse dentate gyrus in a dose-dependent manner when administered at doses ranging from 0.1 to 10 µM. It also protects U2OS cells from calcium-induced mitochondrial dissolution. In a rat model of traumatic brain injury, P7C3-A20 (10 mg/kg, i.p., twice daily for one week) decreases contusion volume, increases proliferation in the SGZ, and decreases the latency to reach the platform in the Morris water maze to sham surgery control levels.{41658} It also prevents or reverses dopaminergic cell death and motor deficits in a 6-OHDA rat model of Parkinson’s disease.{41659}  

     

    Brand:
    Cayman
    SKU:24201 - 5 mg

    Available on backorder

  • PA-457 is a first-in-class inhibitor of HIV-1 maturation, blocking the cleavage of the Gag capsid (CA) precursor, CA-SPI, to mature CA protein during virion maturation.{33662,33663,33664} Specific inhibition of this final rate-limiting step in Gag processing results in the production of immature, non-infectious virus particles.{33662} PA-457 reduced viral load in HIV-infected adults in a dose-dependent fashion, when given in a single oral dose in a clinical study.{33663} It is inactive against HIV-2 or Simian immunodeficiency virus.{33664}  

     

    Brand:
    Cayman
    SKU:21339 -

    Out of stock

  • PA-457 is a first-in-class inhibitor of HIV-1 maturation, blocking the cleavage of the Gag capsid (CA) precursor, CA-SPI, to mature CA protein during virion maturation.{33662,33663,33664} Specific inhibition of this final rate-limiting step in Gag processing results in the production of immature, non-infectious virus particles.{33662} PA-457 reduced viral load in HIV-infected adults in a dose-dependent fashion, when given in a single oral dose in a clinical study.{33663} It is inactive against HIV-2 or Simian immunodeficiency virus.{33664}  

     

    Brand:
    Cayman
    SKU:21339 -

    Out of stock

  • PA-457 is a first-in-class inhibitor of HIV-1 maturation, blocking the cleavage of the Gag capsid (CA) precursor, CA-SPI, to mature CA protein during virion maturation.{33662,33663,33664} Specific inhibition of this final rate-limiting step in Gag processing results in the production of immature, non-infectious virus particles.{33662} PA-457 reduced viral load in HIV-infected adults in a dose-dependent fashion, when given in a single oral dose in a clinical study.{33663} It is inactive against HIV-2 or Simian immunodeficiency virus.{33664}  

     

    Brand:
    Cayman
    SKU:21339 -

    Out of stock

  • PA-457 is a first-in-class inhibitor of HIV-1 maturation, blocking the cleavage of the Gag capsid (CA) precursor, CA-SPI, to mature CA protein during virion maturation.{33662,33663,33664} Specific inhibition of this final rate-limiting step in Gag processing results in the production of immature, non-infectious virus particles.{33662} PA-457 reduced viral load in HIV-infected adults in a dose-dependent fashion, when given in a single oral dose in a clinical study.{33663} It is inactive against HIV-2 or Simian immunodeficiency virus.{33664}  

     

    Brand:
    Cayman
    SKU:21339 -

    Out of stock

  • PA-824 is an anti-tuberculosis (anti-TB) agent that is activated intracellularly via deazaflavin-dependent nitroreductase (Ddn) metabolism into a desnitro metabolite that kills M. tuberculosis by releasing reactive nitrogen species (RNS), including nitric oxide.{16570} It is active against replicating and non-replicating M. tuberculosis but exhibits little or no activity against M. avium, M. smegmatis, M. chelonae, and M. fortuitum.{37419} In vitro, it inhibits growth of susceptible and mono- and multi-drug resistant M. tuberculosis clinical isolates (MICs = 0.015-5 μg/ml).{37419,37420} In vivo, PA-824 (100 mg/kg per day) decreases luminescence in the lung to background levels after 60 days of treatment in a mouse model of systemic infection with a reporter strain of M. tuberculosis.{37419} It also decreases M. tuberculosis burden in the lung and spleen in an aerosol challenged guinea pig model of TB when administered at a dose of 40 mg/kg per day for 30 days.  

     

    Brand:
    Cayman
    SKU:-
  • PA-824 is an anti-tuberculosis (anti-TB) agent that is activated intracellularly via deazaflavin-dependent nitroreductase (Ddn) metabolism into a desnitro metabolite that kills M. tuberculosis by releasing reactive nitrogen species (RNS), including nitric oxide.{16570} It is active against replicating and non-replicating M. tuberculosis but exhibits little or no activity against M. avium, M. smegmatis, M. chelonae, and M. fortuitum.{37419} In vitro, it inhibits growth of susceptible and mono- and multi-drug resistant M. tuberculosis clinical isolates (MICs = 0.015-5 μg/ml).{37419,37420} In vivo, PA-824 (100 mg/kg per day) decreases luminescence in the lung to background levels after 60 days of treatment in a mouse model of systemic infection with a reporter strain of M. tuberculosis.{37419} It also decreases M. tuberculosis burden in the lung and spleen in an aerosol challenged guinea pig model of TB when administered at a dose of 40 mg/kg per day for 30 days.  

     

    Brand:
    Cayman
    SKU:-
  • PA-824 is an anti-tuberculosis (anti-TB) agent that is activated intracellularly via deazaflavin-dependent nitroreductase (Ddn) metabolism into a desnitro metabolite that kills M. tuberculosis by releasing reactive nitrogen species (RNS), including nitric oxide.{16570} It is active against replicating and non-replicating M. tuberculosis but exhibits little or no activity against M. avium, M. smegmatis, M. chelonae, and M. fortuitum.{37419} In vitro, it inhibits growth of susceptible and mono- and multi-drug resistant M. tuberculosis clinical isolates (MICs = 0.015-5 μg/ml).{37419,37420} In vivo, PA-824 (100 mg/kg per day) decreases luminescence in the lung to background levels after 60 days of treatment in a mouse model of systemic infection with a reporter strain of M. tuberculosis.{37419} It also decreases M. tuberculosis burden in the lung and spleen in an aerosol challenged guinea pig model of TB when administered at a dose of 40 mg/kg per day for 30 days.  

     

    Brand:
    Cayman
    SKU:-
  • PA-824 is an anti-tuberculosis (anti-TB) agent that is activated intracellularly via deazaflavin-dependent nitroreductase (Ddn) metabolism into a desnitro metabolite that kills M. tuberculosis by releasing reactive nitrogen species (RNS), including nitric oxide.{16570} It is active against replicating and non-replicating M. tuberculosis but exhibits little or no activity against M. avium, M. smegmatis, M. chelonae, and M. fortuitum.{37419} In vitro, it inhibits growth of susceptible and mono- and multi-drug resistant M. tuberculosis clinical isolates (MICs = 0.015-5 μg/ml).{37419,37420} In vivo, PA-824 (100 mg/kg per day) decreases luminescence in the lung to background levels after 60 days of treatment in a mouse model of systemic infection with a reporter strain of M. tuberculosis.{37419} It also decreases M. tuberculosis burden in the lung and spleen in an aerosol challenged guinea pig model of TB when administered at a dose of 40 mg/kg per day for 30 days.  

     

    Brand:
    Cayman
    SKU:-
  • Apoptosis can be induced when procaspase-3 is activated and converted to caspase-3. Procaspase-activating compound 1 (PAC-1) is a procaspase-3 activator and a potential drug treatment in cancer cell lines with elevated levels of procaspase-3.{14401} PAC-1’s effectiveness was found to be directly proportional to the procaspase-3 concentration present in cells. In cancer cells, PAC-1 had an IC50 value of 3 nM for induction of cell death, whereas in cells from adjacent normal tissue IC50 values of 3.2-8.5 µM were observed.{14401}  

     

    Brand:
    Cayman
    SKU:10009317 - 100 mg

    Available on backorder

  • Apoptosis can be induced when procaspase-3 is activated and converted to caspase-3. Procaspase-activating compound 1 (PAC-1) is a procaspase-3 activator and a potential drug treatment in cancer cell lines with elevated levels of procaspase-3.{14401} PAC-1’s effectiveness was found to be directly proportional to the procaspase-3 concentration present in cells. In cancer cells, PAC-1 had an IC50 value of 3 nM for induction of cell death, whereas in cells from adjacent normal tissue IC50 values of 3.2-8.5 µM were observed.{14401}  

     

    Brand:
    Cayman
    SKU:10009317 - 25 mg

    Available on backorder

  • Apoptosis can be induced when procaspase-3 is activated and converted to caspase-3. Procaspase-activating compound 1 (PAC-1) is a procaspase-3 activator and a potential drug treatment in cancer cell lines with elevated levels of procaspase-3.{14401} PAC-1’s effectiveness was found to be directly proportional to the procaspase-3 concentration present in cells. In cancer cells, PAC-1 had an IC50 value of 3 nM for induction of cell death, whereas in cells from adjacent normal tissue IC50 values of 3.2-8.5 µM were observed.{14401}  

     

    Brand:
    Cayman
    SKU:10009317 - 250 mg

    Available on backorder

  • Apoptosis can be induced when procaspase-3 is activated and converted to caspase-3. Procaspase-activating compound 1 (PAC-1) is a procaspase-3 activator and a potential drug treatment in cancer cell lines with elevated levels of procaspase-3.{14401} PAC-1’s effectiveness was found to be directly proportional to the procaspase-3 concentration present in cells. In cancer cells, PAC-1 had an IC50 value of 3 nM for induction of cell death, whereas in cells from adjacent normal tissue IC50 values of 3.2-8.5 µM were observed.{14401}  

     

    Brand:
    Cayman
    SKU:10009317 - 50 mg

    Available on backorder

  • Pachybasin is an anthraquinone fungal metabolite.{48175,48176,48177} It inhibits the growth of E. coli, S. aureus, B. subtilis, and M. luteus bacteria (MICs = 64, 32, 64, and 64 μg/ml, respectively) and C. albicans, S. cerevisiae, A. niger, A. flavus, and F. oxysporum fungi (MICs = 64, 64, 64, 64, and 16 μg/ml, respectively).{48175} It also induces germ tube malformation in B. graminis fungi.{48176} Pachybasin induces developmental retardation and notochord distortions and increases mortality in zebrafish embryos when used at concentrations ranging from 1 to 100 μM.{48177}  

     

    Brand:
    Cayman
    SKU:27268 - 1 mg

    Available on backorder

  • Paclitaxel, a potent disruptor of microtubules derived from the bark of the Pacific yew tree, is widely used as a chemotherapeutic compound. Tested against a panel of cervical (HeLa), lung (A549), breast (MCF-7), colon (HT-29), ovarian (OVG-1), and pancreatic (PC-Sh) carcinomas, paclitaxel demonstrates IC50 values ranging from 2.5-7.5 nM.{18505} Paclitaxel disrupts multipolar spindle formation, inducing cell cycle arrest in various human cell cancer lines (IC50s = 6.7-18.5 nM) at both prophase and G1.{18494} It initiates apoptosis of cancer cells through multiple mechanisms involving p53-dependent and -independent pathways, Bcl-2 family members, cyclin-dependent kinases, and c-Jun N-terminal kinases/stress-activated protein kinases.{18495}  

     

    Brand:
    Cayman
    SKU:10461 - 100 mg

    Available on backorder

  • Paclitaxel, a potent disruptor of microtubules derived from the bark of the Pacific yew tree, is widely used as a chemotherapeutic compound. Tested against a panel of cervical (HeLa), lung (A549), breast (MCF-7), colon (HT-29), ovarian (OVG-1), and pancreatic (PC-Sh) carcinomas, paclitaxel demonstrates IC50 values ranging from 2.5-7.5 nM.{18505} Paclitaxel disrupts multipolar spindle formation, inducing cell cycle arrest in various human cell cancer lines (IC50s = 6.7-18.5 nM) at both prophase and G1.{18494} It initiates apoptosis of cancer cells through multiple mechanisms involving p53-dependent and -independent pathways, Bcl-2 family members, cyclin-dependent kinases, and c-Jun N-terminal kinases/stress-activated protein kinases.{18495}  

     

    Brand:
    Cayman
    SKU:10461 - 25 mg

    Available on backorder

  • Paclitaxel, a potent disruptor of microtubules derived from the bark of the Pacific yew tree, is widely used as a chemotherapeutic compound. Tested against a panel of cervical (HeLa), lung (A549), breast (MCF-7), colon (HT-29), ovarian (OVG-1), and pancreatic (PC-Sh) carcinomas, paclitaxel demonstrates IC50 values ranging from 2.5-7.5 nM.{18505} Paclitaxel disrupts multipolar spindle formation, inducing cell cycle arrest in various human cell cancer lines (IC50s = 6.7-18.5 nM) at both prophase and G1.{18494} It initiates apoptosis of cancer cells through multiple mechanisms involving p53-dependent and -independent pathways, Bcl-2 family members, cyclin-dependent kinases, and c-Jun N-terminal kinases/stress-activated protein kinases.{18495}  

     

    Brand:
    Cayman
    SKU:10461 - 5 mg

    Available on backorder

  • Paclitaxel, a potent disruptor of microtubules derived from the bark of the Pacific yew tree, is widely used as a chemotherapeutic compound. Tested against a panel of cervical (HeLa), lung (A549), breast (MCF-7), colon (HT-29), ovarian (OVG-1), and pancreatic (PC-Sh) carcinomas, paclitaxel demonstrates IC50 values ranging from 2.5-7.5 nM.{18505} Paclitaxel disrupts multipolar spindle formation, inducing cell cycle arrest in various human cell cancer lines (IC50s = 6.7-18.5 nM) at both prophase and G1.{18494} It initiates apoptosis of cancer cells through multiple mechanisms involving p53-dependent and -independent pathways, Bcl-2 family members, cyclin-dependent kinases, and c-Jun N-terminal kinases/stress-activated protein kinases.{18495}  

     

    Brand:
    Cayman
    SKU:10461 - 50 mg

    Available on backorder

  • Paclitaxel octadecanedioate is a prodrug form of paclitaxel (Item No. 10461) that is comprised of paclitaxel conjugated to 1,18-octadecanedioic acid.{50209} Unlike paclitaxel, it does not promote tubulin polymerization in vitro when used at a concentration of 10 μM. A 5:1 mixture of paclitaxel octadecanedioate:human serum albumin (HSA) is cytotoxic to HT-1080, PANC-1, and HT-29 cells (IC50s = 12, 2.48, and 8.62 nM, respectively). This mixture reduces tumor growth and increases survival in an HT-1080 mouse xenograft model in a dose-dependent manner.  

     

    Brand:
    Cayman
    SKU:28635 - 1 mg

    Available on backorder

  • Paclitaxel octadecanedioate is a prodrug form of paclitaxel (Item No. 10461) that is comprised of paclitaxel conjugated to 1,18-octadecanedioic acid.{50209} Unlike paclitaxel, it does not promote tubulin polymerization in vitro when used at a concentration of 10 μM. A 5:1 mixture of paclitaxel octadecanedioate:human serum albumin (HSA) is cytotoxic to HT-1080, PANC-1, and HT-29 cells (IC50s = 12, 2.48, and 8.62 nM, respectively). This mixture reduces tumor growth and increases survival in an HT-1080 mouse xenograft model in a dose-dependent manner.  

     

    Brand:
    Cayman
    SKU:28635 - 10 mg

    Available on backorder

  • Paclitaxel octadecanedioate is a prodrug form of paclitaxel (Item No. 10461) that is comprised of paclitaxel conjugated to 1,18-octadecanedioic acid.{50209} Unlike paclitaxel, it does not promote tubulin polymerization in vitro when used at a concentration of 10 μM. A 5:1 mixture of paclitaxel octadecanedioate:human serum albumin (HSA) is cytotoxic to HT-1080, PANC-1, and HT-29 cells (IC50s = 12, 2.48, and 8.62 nM, respectively). This mixture reduces tumor growth and increases survival in an HT-1080 mouse xenograft model in a dose-dependent manner.  

     

    Brand:
    Cayman
    SKU:28635 - 5 mg

    Available on backorder

  • Paclitaxel octadecanedioate is a prodrug form of paclitaxel (Item No. 10461) that is comprised of paclitaxel conjugated to 1,18-octadecanedioic acid.{50209} Unlike paclitaxel, it does not promote tubulin polymerization in vitro when used at a concentration of 10 μM. A 5:1 mixture of paclitaxel octadecanedioate:human serum albumin (HSA) is cytotoxic to HT-1080, PANC-1, and HT-29 cells (IC50s = 12, 2.48, and 8.62 nM, respectively). This mixture reduces tumor growth and increases survival in an HT-1080 mouse xenograft model in a dose-dependent manner.  

     

    Brand:
    Cayman
    SKU:28635 - 500 µg

    Available on backorder

  • Paclitaxel-d5 contains five deuterium atoms. It is intended for use as an internal standard for the quantification of paclitaxel (Item No. 10461) using GC- or LC-MS. Paclitaxel is cytotoxic against a variety of cancer cell lines with IC50 values ranging from 2.5-7.5 nM.{18505} It disrupts multipolar spindle formation, inducing cell cycle arrest in various human cell cancer lines (IC50s = 6.7-18.5 nM) at both prophase and G1.{18494} It also initiates apoptosis of cancer cells through multiple mechanisms involving p53-dependent and -independent pathways, Bcl-2 family members, cyclin-dependent kinases, and c-Jun N-terminal kinases/stress-activated protein kinases.{18495}  

     

    Brand:
    Cayman
    SKU:22092 -

    Out of stock

  • Paclobutrazol (PBZ) is a triazole-containing plant growth retardant that is known to inhibit the biosynthesis of gibberellins.{30671,21397} It also has antifungal activities.{30669} PBZ, which is transported acropetally in plants, can also suppress the synthesis of abscisic acid and induce chilling tolerance in plants.{30671,30667,30668} PBZ is typically used to support research on the role of gibberellins in plant biology.{30670,30666}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • FMS-like tyrosine kinase 3 (FLT3) and Janus kinase 2 (JAK2) are tyrosine kinases that mediate cytokine signaling and are frequently mutated in cancers, particularly acute myeloid leukemia.{27422,27424} Pacritinib is an inhibitor of both FLT3 and JAK2 (IC50s = 22 and 23 nM, respectively).{27422} It also blocks the activities of the FLT3 D835Y mutant, FLT3 with internal tandem duplications (ITDs), and JAK2 with a V617F substitution (IC50s = 6, 20-180, and 220 nM, respectively).{27422} Pacritinib also inhibits JAK1, JAK3, and TYK2 (IC50s = 1280, 520, and 50 nM, respectively).{27422} Pacritinib is orally bioavailable, inhibiting FLT3 and JAK2 signaling, tumor growth, and metastasis in xenografts in mice.{27422} It is synergistic with the histone deacetylase inhibitor pracinostat (also known as SB 939, Item No. 10443), decreasing cell proliferation and inducing apoptosis in cells carrying either the JAK2 V617F mutation or FLT3 with ITDs, both in vitro and in vivo.{27423} Pacritinib has potential in resolving hematological malignancies.{27424}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • FMS-like tyrosine kinase 3 (FLT3) and Janus kinase 2 (JAK2) are tyrosine kinases that mediate cytokine signaling and are frequently mutated in cancers, particularly acute myeloid leukemia.{27422,27424} Pacritinib is an inhibitor of both FLT3 and JAK2 (IC50s = 22 and 23 nM, respectively).{27422} It also blocks the activities of the FLT3 D835Y mutant, FLT3 with internal tandem duplications (ITDs), and JAK2 with a V617F substitution (IC50s = 6, 20-180, and 220 nM, respectively).{27422} Pacritinib also inhibits JAK1, JAK3, and TYK2 (IC50s = 1280, 520, and 50 nM, respectively).{27422} Pacritinib is orally bioavailable, inhibiting FLT3 and JAK2 signaling, tumor growth, and metastasis in xenografts in mice.{27422} It is synergistic with the histone deacetylase inhibitor pracinostat (also known as SB 939, Item No. 10443), decreasing cell proliferation and inducing apoptosis in cells carrying either the JAK2 V617F mutation or FLT3 with ITDs, both in vitro and in vivo.{27423} Pacritinib has potential in resolving hematological malignancies.{27424}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • FMS-like tyrosine kinase 3 (FLT3) and Janus kinase 2 (JAK2) are tyrosine kinases that mediate cytokine signaling and are frequently mutated in cancers, particularly acute myeloid leukemia.{27422,27424} Pacritinib is an inhibitor of both FLT3 and JAK2 (IC50s = 22 and 23 nM, respectively).{27422} It also blocks the activities of the FLT3 D835Y mutant, FLT3 with internal tandem duplications (ITDs), and JAK2 with a V617F substitution (IC50s = 6, 20-180, and 220 nM, respectively).{27422} Pacritinib also inhibits JAK1, JAK3, and TYK2 (IC50s = 1280, 520, and 50 nM, respectively).{27422} Pacritinib is orally bioavailable, inhibiting FLT3 and JAK2 signaling, tumor growth, and metastasis in xenografts in mice.{27422} It is synergistic with the histone deacetylase inhibitor pracinostat (also known as SB 939, Item No. 10443), decreasing cell proliferation and inducing apoptosis in cells carrying either the JAK2 V617F mutation or FLT3 with ITDs, both in vitro and in vivo.{27423} Pacritinib has potential in resolving hematological malignancies.{27424}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • pacSphingosine (d18:1) is a photoreactive probe for the study of sphingosine metabolism.{45245} It contains a terminal clickable alkyne moiety and a photoactivatable diazirine group that allow its interaction with sphingosine binding proteins and photo-activated cross-linking of its interacting partners, respectively. pacSphingosine (d18:1) has been used to monitor the metabolism of sphingosine and visualize protein-lipid interaction complexes in S1PL-/- mouse embryonic fibroblasts (MEFs).  

     

    Brand:
    Cayman
    SKU:25364 - 1 mg

    Available on backorder

  • pacSphingosine (d18:1) is a photoreactive probe for the study of sphingosine metabolism.{45245} It contains a terminal clickable alkyne moiety and a photoactivatable diazirine group that allow its interaction with sphingosine binding proteins and photo-activated cross-linking of its interacting partners, respectively. pacSphingosine (d18:1) has been used to monitor the metabolism of sphingosine and visualize protein-lipid interaction complexes in S1PL-/- mouse embryonic fibroblasts (MEFs).  

     

    Brand:
    Cayman
    SKU:25364 - 500 µg

    Available on backorder

  • Cayman’s PAD1 Inhibitor Screening Assay Kit (AMC) provides a convenient method for screening human PAD1 inhibitors. This assay utilizes a fluorescent substrate (Z-Arg-AMC) consisting of an arginine residue, a carboxybenzyl group, and a fluorophore (7-amino-4-methylcoumarin, AMC).{31179} Acylation of AMC onto the arginine residue masks the fluorescence of the fluorophore. In the absence of PAD1, the substrate remains unaltered, allowing the developer to release free AMC. In the presence of PAD1, the arginine of the substrate is citrullinated, and while the reaction is quenched by the addition of developer, free AMC is not released. Fluorescence is analyzed with an excitation wavelength of 355-365 nm and an emission wavelength of 445-455 nm. The fluorescent signal is inversely proportional to the amount of citrullination by PAD1.  

     

    Brand:
    Cayman
    SKU:701440 - 96 wells

    Available on backorder

  • Cayman’s PAD1 Inhibitor Screening Assay Kit (Ammonia) provides a convenient method for screening human PAD1 inhibitors. PAD1 deiminates N-α-benzoyl-L-arginine ethyl ester (BAEE), a non-natural substrate with similar kinetic properties to the natural substrates, producing ammonia.{18133} Ammonia reacts with a detector resulting in a fluorescent product. Fluorescence is then analyzed with an excitation wavelength of 405-415 nm and an emission wavelength of 470-480 nm.  

     

    Brand:
    Cayman
    SKU:701450 - 96 wells

    Available on backorder

  • Protein arginine deiminases (PADs) are guanidine-modifying enzymes belonging to the amidinotransferase superfamily and are designated PAD1-4, and PAD6. PADs are calcium-dependent enzymes that catalyze the post-translational modification of target proteins by converting arginine to citrulline.{19489, 18141} The excess deimination of target proteins can result in the production of anti-citrullinated protein antibodies (ACPAs) which can be indicators of a number of disease states.{31883} The various PADs exhibit tissue specific expression and different subcellular localization.{19488} PAD1 is expressed in uterus and throughout the epidermis. PAD1 and PAD3 are speculated to mediate deamination of epidermal filaggrin (filament aggregation protein) and keratins, proteins involved in maintaining skin hydration.{19490} The predicted size for PAD1 is 74.7 kD and Cayman’s PAD1 monoclonal antibody (clone 6B4) detects a band at ~74 kD by Western blot.  

     

    Brand:
    Cayman
    SKU:22997 - 100 µg

    Available on backorder

  • Immunogen: Recombinant human PAD1 protein • Clone designation: 6B4 • Host: Mouse • Cross Reactivity: (-) PAD2, PAD3, and PAD4 • Species Reactivity: (+) Human • Isotype: IgG2b • Applications: ELISA and WB  

     

    Brand:
    Cayman
    SKU:22997- 100 µg

    Available on backorder

  • Immunogen: Recombinant human PAD1 protein • Clone designation: 6B4 • Host: Mouse • Cross Reactivity: (-) PAD2, PAD3, and PAD4 • Species Reactivity: (+) Human • Isotype: IgG2b • Applications: ELISA and WB  

     

    Brand:
    Cayman
    SKU:22997- 100 µg
  • Peptidylarginine deiminases (PADs) are a family of five enzymes that catalyze the conversion of arginine to citrulline in peptides and proteins. PAD2 is the most widely expressed and conserved member across mammalian species, implying it is the ancestral homologue of the PADs. Cayman’s PAD2 (human) ELISA Kit is a sandwich assay that can be used to measure PAD2 in tissue culture medium, cell lysates, plasma, and serum.  

     

    Brand:
    Cayman
    SKU:501450 - 96 wells

    Available on backorder

  • Protein arginine deiminase 2 (PAD2) is a guanidino-modifying enzyme that catalyzes the conversion of specific arginine residues to citrulline in a calcium-dependent manner. This enzyme has been implicated in several diseases, including rheumatoid arthritis (RA), retinal degeneration, and certain cancers. PAD2 has been shown to modify vimentin, fibrinogen, and β/γ-actin. Extracellular levels of PAD2 are increased in the lungs of smokers, providing a link between smoking as a risk factor for RA and anti-citrullinated protein antibodies among RA patients. Cayman’s PAD2 Inhibitor Screening Assay Kit (AMC) provides a convenient method for screening human PAD2 inhibitors.  

     

    Brand:
    Cayman
    SKU:701390 - 96 wells

    Available on backorder